Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 36, 2006 - Issue 2-3
808
Views
40
CrossRef citations to date
0
Altmetric
Review Article

Modulation of the growth hormone–insulin-like growth factor (GH–IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: An emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression. A review

Pages 119-218 | Received 01 Dec 2005, Published online: 22 Sep 2008

References

  • Aboulafia DM, Norris D, Henry D, Grossman RJ, Thommes J, Bundow D, Yocum RC, Stevens V. 9-cis retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicentre clinical trial. Archives of Dermatology 2003; 139: 178–186
  • Adachi J, Mori Y, Matsui S, Matsuda T. Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin. Toxicological Science 2004; 80: 161–169
  • Adams KE, Newton KM, Chen C, Emerson SS, Potter JD, White E, Lampe JW. Spy isoflavones do not modulate circulating insulin-like growth factor concentrations in an older population in an intervention trial. Journal of Nutrition 2003; 133: 1316–1319
  • Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mekhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-1-induced signalling in an autochthonous mouse model of prostate cancer. Cancer Research 2004; 64: 8715–8722
  • Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism. Journal of Clinical Endocrinology and Metabolism 2003; 88: 2860–2868
  • Aimaretti G, Corneli G, Di Somma C, Baldelli R, Gasco V, Rovere S, Migliaretti G, Colao A, Tamburrano G, Lombardi G, Ghigo E, Cammanni F. Different degrees of GH deficiency evidenced by GHRH + arginine test and IGF-1 levels in adults with pituitary disease. Journal of Endocrinological Investigation 2005; 28: 247–252
  • Akamizu T, Takaya K, Irako T, Hosoda H, Teramukai S, Matsuyama A, Tada H, Miura K, Shimizu A, Fukushima M, Yokode M, Tanaka K, Kangawa K. Pharmacokinetics, safety, and endocrine and appetite effects of fhrelin administration in young healthy subjects. European Journal of Endocrinology 2004; 150: 447–455
  • Al-Damluji S, Fancis D. Activation of central alpha 1-adrenoceptors in humans stimulates secretion of prolactin and TSH, as well as ACTH. American Journal of Physiology 1993; 264: E208–E214
  • Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ. The associations of diet with serum insulin-like growth factor 1 and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiology, Biomarkers and Prevention 2002; 11: 1441–1448
  • Allen NE, Appleby PN, Kaaks R, Rinaldi S, Davey GK, Key TJ. Lifestyle determinants of serum insulin-like growth factor-1 (IGF-1), C-peptide and hormone binding protein levels in British women. Cancer Causes and Control 2003; 14: 65–74
  • Alvarez P, Isidro L, Peino R, Leal-Cerro A, Casanueva FF, Dieguez C, Cordido F. Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients. Clinical Endocrinology 2003; 59: 431–436
  • Amador-Noguez D, Zimmerman J, Venable S, Darlington G. Gender-specific alterations in gene expression and loss of liver sexual dimorphism in the long-lived Ames dwarf mice. Biochemical and Biophysical Research Communications 2005; 332: 1086–1100
  • Anderson LL, Jeftinija S, Scanes CG. Growth hormone secretion: molecular and cellular mechanisms and in vivo approaches. Experimental Biological Medicine 2004; 229: 291–302
  • Arce V, Lima L, Lois N, Rodriguez A, Diaz MJ, Treguerres JA, Devesa J. Role of centrol dopaminergic pathways in the neural control of growth hormone secretion in normal men: studies with meclopramide. Neuroendocrinology 1991; 53: 143–149
  • Arjmandi BH, Khalil DA, Smith BJ, Lucas EA, Juma S, Payton ME, Wild RA. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. Journal of Clinical Endocrinology and Metabolism 2003; 88: 1048–1054
  • Arjmandi B, Juma S, Beharka A, Bapnu M, Akhter M, Meydani S. Vitamin E improves bone quality in the aged but not in young male mice. Journal of Nutritional Biochemistry 2002; 13: 543
  • Arnold JT, Le H, McFann KK, Blackman MR. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. American Journal of Physiology. Endocrinology and Metabolism 2005; 288: E573–E584
  • Arsenault JT, Fairchild WL, MacLatchy DL, Burridge L, Haya K, Brown SB. Effects of water-borne 1-nonylphenol and 17beta-estradiol exposures during parr-smolt transformation on growth and plasma IGF-1 of Atlantic salmon (Salmo salar L.). Aquatic Toxicology 2004; 66: 255–265
  • Arvat E, Gianotti L, Rammunni J, DiVito L, Deghenghi R, Camanni F, Ghigo E. Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man. Journal of Endocrinological Investigation 1996; 19: 25–29
  • Arvat E, Maccagno B, Ramunni J, Gianotti L, Di L, Deghenghi R, Camanni F, Ghigo E. Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarhelin, a synthetic hexapeptide, in man. Journal of Endocrinological Investigation 1997; 20: 122–127
  • Attanasio R, Barausse M, Cozzi R. Raloxifene lowers IGF-1 levels in acromegalic women. European Journal of Endocrinology 2003; 148: 443–448
  • Attvall S, Fowelin J, Lager I, Von H, Smith U. Smoking induces insulin-resistance — a potential link with the insulin resistance syndrome. Journal of International Medicine 1993; 233: 327–332
  • Auerbach SS, Stoner MA, Su S, Omiecinski CJ. Retinoid X receptor-alpha-dependent transactivation by a naturally occurring structural variation of human constitutive androstane receptor (NR1I3). Molecular Pharmacology 2005; 68: 1239–1253
  • Avis I, Hong SH, Martinez A, Moody T, Choi YH, Trepel J, Das R, Jett M, Mulshine JL. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB Journal 2001; 15: 1007–1010
  • Awede BL, Thissen JP, Lebacq J. Role of IGF-1 and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol. American Journal of Physiology, Endocrinology and Metabolism 2002; 282: E31–E37
  • Bach LA, Headey SJ, Norton RS. IGF-binding proteins — the pieces are falling into place. Trends in Endocrinology and Metabolism 2005; 16: 228–234
  • Bajetta E, Ferrari L, Celio L, Mariani L, Miceli R, Di A, Zilembo N, Buzzoni R, Soagnoli I, Martinetti A, Bichisao E, Sergni E. The aromatase inhibitor letrozole in advanced breast cancer: Effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels. Journal of Steroid Biochemistry and Molecular Biology 1997; 63: 261–267
  • Balogh A, Kauf E, Vollanth R, Graser G, Klinger G, Oettel M. Effects of two oral contraceptives on plasma levels of insulin-like growth factor 1 (IGF-1) and growth hormone (hGH). Contraception 2000; 62: 259–269
  • Barb CR, Hausman GJ, Czaja K. Leptin: a metabolic signal affecting central regulation of reproduction in the pig. Domestic Animal Endocrinology 2005; 29: 186–192
  • Barbarino A, Colasanti S, Corsello SM, Satta MA, Della Casa S, Rota CA, Tartaglione R, Barini A. Dexamethasone inhibition of interferon-alpha 2-induced stimulation of cortisol and growth hormone secretion in chronic myeloproliferative syndrome. Journal of Clinical Endocrinology and Metabolism 1995; 80: 1329–1332
  • Barbieri C, Ferrari C, Borzio M, Piepoli V, Caldara R. Metabolic effects of chronic prazosin treatment. Hormone and Metabolic Research 1980; 12: 331–334
  • Barlas N, Semanoglu G, Kockaya A, Songur S. Effects of carbendazim on rat thyroid, parathyrol, pituitary and adrenal glands and their hormones. Human and Experimental Toxicology 2002; 21: 217–221
  • Baudler S, Baumgartl J, Hampel B, Buch T, Waisman A, Snapper CM, Krone W, Bruning JC. Insulin-like growth factor-1 controls type 1 T-cell independent B cell response. Journal of Immunology 2005; 174: 5516–5525
  • Baum WF, Kloditz E, Schneyer U. Inhibition of growth hormone secretion by theophylline in asthmatic children. Pneumologie 1996; 50: 238–241
  • Bauman WA, Spungen AM, Zhong YG, Tsitouras PD. Chronic baclofen therapy improves the blunted growth hormone response to intravenous arginine in subjects with spinal cord injury. Journal of Clinical Endocrinology and Metabolism 1994; 78: 1135–1138
  • Baumann G. Growth hormone binding protein. The soluble growth hormone receptor. Minerva Endocrinologica 2002; 27: 265–276
  • Beck V, Rohr U, Jungbauer A. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? Journal of Steroid Biochemistry and Molecular Biology 2005; 94: 499–518
  • Ben-dor A, Nahum A, Danilenko M, Giat Y, Stahl W, Martin HD, Emmerich T, Noy N, Levy J, Sharoni Y. Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells. Archives of Biochemistry and Biophysics 2001; 391: 295–302
  • Benini S, Manara MC, Baldini N, Cerisano V, Serra M, Mercuri M, Lollini PL, Nanni P, Scotland K. Inhibition of insulin-like growth factor 1 receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells. Contraception 2001; 7: 1790–1797
  • Bereket A, Lang CH, Wilson TA. Alterations in the growth hormone–insulin-like growth factor axis in insulin-dependent diabetes mellitus. Hormone and Metabolic Research 1999; 31: 172–181
  • Berry WD, Jr, Moriarty CM, Lau YS. Lead attenuation of episodic growth hormone secretion in male rats. International Journal of Toxicology 2002; 21: 93–98
  • Besnard V, Nabeyrat E, Henroin-Caude A, Chadelat K, Perin LM, Le Y, Clement A. Protective role of retinoic acid from antiapoptotic action of TNF-alpha on lung epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 2002; 282: L863–L8
  • Bhansali A, Valayutham P, Sialy R, Sethi B. Effect of opiates on growth hormone secretion in acromegaly. Hormone and Metabolic Research 2005; 37: 425–427
  • Bhathena SJ, Berlin E, Judd JT, Kim YC, Law JS, Bhagavan HN, Ballard-Barbash R, Nair PP. Effects of omega 3 fatty acids and vitamin E on hormones involved in carbohydrate and pilid metabolism in men. American Journal of Clinical Nutrition 1991; 54: 684–688
  • Birkelo CP. Pharmaceuticals, direct-fed microbials, and enzymes for enhancing growth and feed efficiency of beef. Veterinary Clinics of North America. Food Animal Practice 2003; 19: 599–624
  • Boisseau N, Rannou F, Delamarche P, Bentue-Ferrer D, Gratas-Delamarche A. Glucose tolerance during moderate prolonged exercise in women with oral contraceptives as compared with controls. Journal of Sports Medicine and Physical Fitness 2001; 41: 203–209
  • Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment. Minerva Endocrinologica 1999; 24: 51–55
  • Boomsma F, Rupreht J, Man in ‘t Veld AJ, De Jong FH, Dzoljic M, Lachmann B. Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxide. Anaesthesia 1990; 45: 273–278
  • Borges MH, Pinto AC, DiNinno FB, Camacho-Hubner C, Grossman A, Kater CE, Lengyel AM. IGF-1 levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man. Journal of Endocrinological Investigation 1999; 22: 12–17
  • Bowman CJ, Turner KJ, Sar M, Barlow NJ, Gaido KW, Foster PMD. Altered gene expression during rat wolffian duct development following di(n-butyl) phthalate exposure. Toxicological Sciences 2005; 86: 161–174
  • Bozzola M, Comoli P, Bozzola E, Tinelli C, Marello A, Stabile M, Mazzola A, Locatelli V. Low dose of insulin for assessment of growth hormone and cortisol release in short children. Journal of Paediatric Endocrinology and Metabolism 2005; 18: 815–818
  • Broglio F, Benso A, Gottero C, Vitro LD, Granata R, Arvat E, Bobbio M, Trevi G, Ghigo E. Effect of digoxin on the somatotroph responsiveness to growth hormone–releasing hormone (GHRH) alone or combined with arginine in normal young volunteers. Clinical Endocrinology 2001; 55: 755–758
  • Brooks JD, Thompson LU. Mammalian lignans and genistein decrease the activities of aromatase and 17beat-hydroxysteroid dehydrogenase in MCF-7 cells. Journal of Steroid Biochemistry and Molecular Biology 2005; 94: 461–467
  • Brown A, Jolly P, Wei H. Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apoptosis and regulation of tyrosine kinase activity and N-myc expression. Carcinogenesis 1998; 19: 991–997
  • Brown TT, Dobs AS. Endocrine effects of marijuana. Journal of Clinical Pharmacology 2002; 42: 90S–96S
  • Budd GT, Adamson PC, Gupta M, Homayoun P, Sandstorm SK, Murphy RF, McLain D, Tuason L, Peereboom D, Bukowski RM, Ganapathi R. Phase 1/2 trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer. Clinical Cancer Research 1998; 4: 635–642
  • Buttriss J. Demystifying phytochemicals. Biologist 2004; 51: 105–108
  • Bylund A, Lundin E, Zhang JX, Nordin A, Kaaks R, Stenman UH, Aman P, Adlercreutz H, Nilsson TK, Hallmans G, Bergh A, Stattin P. Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer. European Journal of Cancer Prevention 2003; 15: 407–415
  • Cavagnini F, Di A, Invitto C, Raggi U, Alessandrini P, Pinto M, Girotti G, Vigo P. Effects of acetylsalicylic acid and indomethacin on growth hormone secretion in man. Metabolism 1977; 26: 193–200
  • Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. Journal of Nutrition 2005; 135: 310–316
  • Camacho A, Mathews SC, Dimsdale JE. Use of GHB compounds by HIV-positive individuals. American Journal of Addiction 2004; 13: 120–127
  • Campagnoli C, Abba C, Ambroggio S, Peris C. Differential effects of progestins on the circulating IGF-I system. Maturitas 2003; 1(Suppl.)39–44
  • Campbell MJ, Woodside JV, Secker-Walker J, Titcomb A, Leathem AJ. IGF status is altered by tamoxifen in patients with breast cancer. Molecular Pathology 2001; 54: 307–310
  • Carew LB, Jr, Gestrone TA, Alster FA, Scanes CG. Effect of phosphorous deficiency on thyroid function and growth hormone in the white Leghorn male. Poultry Science 1985; 64: 2010–2012
  • Caviezel F, Catteneo AG, Tell A, Corino T, Mascherpa M. The effect of acetylsalicylic acid and diclofenac on stimulated growth hormone and prolactin secretion in humans. International Journal of Clinical Pharmacology, Therapy and Toxicology 1983; 21: 502–504
  • Cavun S, Savci V. CDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement. Fundamental and Clinical Pharmacology 2004; 18: 513–523
  • Cella SG, Locatelli V, De Gennaro V, Wehrenberg WB, Muller EE. Pharmacological manipulations of alpha-adrenoceptors in the infant rat and effects on growth hormone secretion. Study of the underlying mechanism of action. Endocrinology 1987; 120: 1639–1643
  • Cesi V, Vitali R, Tanno B, Giuffida ML, Sesti F, Mancini C, Raschella G. Insulin-like growth factor binding protein 5: contribution to growth and differentiation of neuroblastoma cells. Annals of the New York Academy of Sciences 2004; 1028: 59–68
  • Cha MC, Rojhani A. Zinc deficiency inhibits the direct growth effect of growth hormone on the tibia of hypophysectomized rats. Biological Trace Element Research 1997; 59: 99–111
  • Chambery D, De Galle B, Babajko S. Retinoic acid stimulates IGF binding protein (IGFBP)-6 and depresses IGFBP-2 and IGFBP-4 in SK-N-SH human neuroblastoma cells. Journal of Endocrinology 1998; 159: 227–232
  • Cheema U, Brown R, Mudera V, Yang SY, McGrouther G, Goldspink G. Mechanical signals and IGF-1 gene splicing in vitro in relation to development of skeletal muscle. Journal of Cell Physiology 2005; 202: 67–75
  • Chen W, Wong M. Genistein enhances insulin-like growth factor signalling pathway in human breast cancer (MCF-7) cells. Journal of Clinical Endocrinology and Metabolism 2004; 89: 2351–2359
  • Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. Expression patterns of mouse and human CYP orthologs (families 1–4) during development and in different adult tissues. Archives of Biochemistry and Biophysics 2005; 436: 50–61
  • Chromiak JA, Antonio J. Use of amino acids as growth hormone-releasing agents by athletes. Nutrition 2002; 18: 657–661
  • Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Medicine Reviews 2005; 9: 11–24
  • Cohick WS, Wang B, Verma P, Boisclair YR. Insulin-like growth factor 1 (IGF-1) and cyclic adenosine 3′,5′-monophosphate regulate IGF-binding protein-3 gene expression by transcriptional and posttranscriptional mechanism in mammary epithelial cells. Endocrinology 2000; 141: 4583–4591
  • Coiro V, d’Amato L, Borciani E, Rossi G, Camellini L, Maffei ML, Pignatti D, Chioder P. Nicotine from cigarette smoking enhances clonidine-induced increase of serum growth hormone concentrations in men. British Journal of Clinical Pharmacology 1984; 18: 802–805
  • Colao A, Vitale G, Pivonello R, Ciccarelli A, Di Somma C, Lombardi G. The heart: an end-organ of GH actiob. European Journal of Endocrinology 2004; 151(Suppl. 1)S93–S101
  • Collier SR, Casey DP, Kanaley JA. Growth hormone responses to varying doses of oral arginine. Growth Hormone and IGF Research 2004; 15: 136–139
  • Condren RM, Lucey JV, Thakore JH. A preliminary study of baclofen-induced growth hormone release in generalised social phobia. Human Psychopharmacology 2003; 18: 125–130
  • Corbalan R, Acevedo M, Godoy M, Jalil J, Campusano C, Klassen J. Enalapril restores depressed circulating insulin-like growth factor 1 in patients with chronic heart failure. Journal of Cardiac Failure 1998; 4: 115–119
  • Corsello SM, Rota CA, Putignano P, Della S, Barnabei A, Migneco MG, Vangeli V, Barini A, Mandala M, Barone C, Barbarino A. Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-1 serum levels in women with breast cancer. European Journal of Endocrinology 1998; 139: 309–313
  • Costello LC, Franklin RB, Feng P, Tan M, Bagasra O. Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States). Cancer Causes and Control 2005; 16: 901–915
  • Coutant R, Boux De Casson F, Douay O, Mathieu E, Rouleau S, Beringue F, Gillard P, Limal JM, Descamps P. Relationships between placental GH concentrations and maternal smoking, newborn gender, and maternal leptin: possible implications for birth weight. Journal of Clinical Endocrinology and Metabolism 2001; 86: 4854–4859
  • Cozzi R, Barausse M, Lodrini S, Lasio G, Attanasio R. Estroprogestinic pill normalizes IGF-1 levels in acromegalic women. Journal of Endocrinological Investigation 2003; 26: 347–352
  • Croutch CR, Lebofsky M, Schramm KW, Terranova PF, Rozman KK. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin (HxDD) alter body weight by decreasing insulin-like growth factor 1 (IGF-1) signalling. Toxicological Sciences 2005; 85: 560–571
  • Cuneo RC, Hickman PE, Wallace JD, The BT, Ward G, Veldhuis JD, Waters MJ. Altered endogenous growth hormone secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease. Clinical Endocrinology 1995; 43: 265–275
  • Cunoe RC, Livesey JH, Nicholls MG, Espiner EA, Donald RA. Effects of alpha-2-adrenoceptor blockade by yohimbine on the hormonal response to hypoglycaemic stress in normal man. Hormone and Metabolic Research 1989; 21: 33–36
  • Dahl GE, Auchtung TL, Kendell PE. Photoperiodic effects on endocrine and immune function in cattle. Reproduction 2002; 59(Suppl.)191–201
  • Daniel JA, Elsasser TH, Martinez A, Stelle B, Whitlock BK, Sartin JL. Interleukin-1beta and tumor necrosis factor-alpha mediation of endotoxin action on growth hormone. American Journal of Physiology. Endocrinology and Metabolism 2005; 289: E650–E657
  • De Arcangelis V, Coletti D, Conti M, Lagarde M, Molinaro M, Adamo S, Nemov G, Naro F. IGF-1-induced differentiation of L6 myogenic cells requires the activity of cAMP-phosphodiesterase. Molecular Biology of the Cell 2003; 14: 1392–1404
  • de Borja Goncalves Guerra A, Castel S, Benedito-Silva AA, Calil HM. Neuroendocrine effects of quetiapine in healthy volunteers. International Journal of Neuropsychopharmacology 2005; 8: 49–57
  • De Marinis L, Mancini A, Valle D, Bianchi A, De Luca AM, Fulghesu AM, Villa P, Mancuso S, Lanzone A. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects. International Journal of Obesity and Related Metabolic Disorders 1997; 21: 1076–1081
  • De Metz J, Sprangers F, Endert E, Ackermans MT, ten Berge LJ, Sauerwein HP, Romijin JA. Interferon-gamma has immunomodulatory effects with minor endocrine changes and metabolic effects. Journal of Applied Physiology 1999; 86: 517–522
  • de Prati AC, Ciampa AR, Cavalieri E, Zaffini R, Darra E, Menegazzi M, Suzuki H, Mariotto S. STAT1 as a new molecular target of anti-inflammatory treatment. Current Medicinal Chemistry 2005; 12: 1819–1828
  • Dearth RK, Hiney JK, Srivastava V, Burdick SB, Bratton GR, Dees WL. Effects of lead (Pb) exposure during gestation and lactation on female pubertal development in the rat. Reproductive Toxicology 2002; 16: 343–352
  • Dees WL, Srivatava VK, Hiney JK. Alcohol alters insulin-like growth factor-1 activated oct 2 POU domain gene expression in the immature female hypothalamus. Journal of Studies on Alcohol 2005; 66: 35–45
  • Del Monte P, Bernasconi D, De Conca V, Randazzo M, Meozzi M, Badaracco B, Mesiti S, Marrugo M. Endocrine evaluation in patients treated with interferon-alpha for chronic hepatitis C. Hormone Research 1995; 44: 105–109
  • Del Monte P, Laurino C, Arvigo M, Paalermo C, Minuto F, Barreca A. Effects of alpha-interferon on insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in-vitro. Journal of Endocrinological Investigation 2005; 28: 432–439
  • Del Rincon SV, Rousseau C, Samanta R, Miller WH, Jr. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 30kinase/AKT pathwat. Oncogene 2003; 22: 3353–3360
  • Deldicque L, Louis M, Theisen D, Nielens H, Dehoux M, Thissen JP, Rennie MJ, Francauz M. Increased IGF mRNA in human skeletal muscle after creatine supplementation. Medicine and Science in Sports and Exercise 2005; 37: 731–736
  • DeLellis K, Rinaldi S, Kaaks RJ, Kolonel LN, Henderson B, Le Marchand L. Dietary and lifestyle correlates of plasma insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. Cancer Epidemiology. Biomarkers and Prevention 2004; 13: 1444–1451
  • Demori I, Balocco S, Gerdoni E, Fugassa E, Voci A. Retinoic acid increases insulin-like growth factor-binding protein-4 expression in cultured rat hepatocytes. Hormone and Metabolic Research 2004; 36: 7–13
  • Deng J. Effects of 1,25-(OH)2D3 on the secretion of growth hormone by human pituitary growth hormone-secreting tumors in vitro. Acta Academiae Medicinae Sinicae 1992; 14: 210–214
  • Desaulniers D, Leingartner K, Wade M, Fintelman E, Yagminas A, Foster WG. Effects of acute exposure to PCBs 126 and 153 on anterior pituitary and thyroid hormones and FSH isoforms in adult Sprague Dawley male rats. Toxicological Sciences 1999; 47: 158–169
  • Dhir RN, Dworakowski W, Tangavel C, Shapiro BH. Sexual dimorphic regulation of hepatic isoforms of human cytochrome P450 by growth hormone. Journal of Pharmacological and Experimental Therapeutics 2005; 316: 87–94
  • Di Luigi L, Guidetti L, Romanelli F, Baldari C, Conte D. Acetylsalicylic acid inhibits the pituitary response to exercise-related stress in humans. Medicine and Science in Sports and Exercise 2001; 22: 2029–2035
  • Diaz-Torga G, Feierstein C, Libertun C, Gelman D, Kelly MA, Low MJ, Rubinstein M, Becu-Villalobos D. Disruption of the D2 dopamine receptor alters GH and IGF-1 secretion and causes dwarfism in male mice. Endocrinology 2002; 143: 1270–1279
  • Dickson LC, MacNeill JD, Lee S, Fesser AC. Determination of beta-agonist residues in bovine urine using liquid chromatography-tandem-mass spectrometry. Journal of AOAC International 2005; 88: 46–56
  • Diez J, Laviades C. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captorpil, lisinopril and quinapril. Journal of Hypertension 1994; 12: S31–S36
  • Dimitrov S, Lange T, Fehm HL, Born J. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain, Behaviour and Immunology 2004; 18: 368–374
  • Duan C, Xu Q. Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. General and Comparative Endocrinology 2005; 142: 44–52
  • Durai R, Yang W, Gupta S, Seidalian AM, Winslet MC. The role of the insulin-like growth factor system in colorectal cancer: a review of the current knowledge. International Journal of Colorectal Disease 2005; 20: 203–220
  • Duschek EJ, Gooren LJ, Netelenbos C. Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3. Maturitias 2005; 51: 286–293
  • Elango A, Shepherd B, Chen TT. Effects of endocrine disruptors on the expression of growth hormone and prolatin mRNA in the rainbow trout pituitary. General and Comparative Endocrinology 2005; 145: 116–127
  • Elmazar MM, Nau H. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands. Archives of Toxicology 2004; 78: 660–668
  • Eng ET, Ye J, Williams D, Phung S, Moore RE, Young MK, Gruntmanis U, Braunstein G, Chen S. Suppression of estrogen biosynthesis by procyanidin dimmers in red wine and grape seed. Cancer Research 2003; 63: 8516–8522
  • Engstrom BE, Karlsson FA, Wide L. Marked gender differences in ambulatory morning growth hormone values in young adults. Clinical Chemistry 1998; 44: 1289–1295
  • Engstrom BE, Burman P, Johansson AG, Wide L, Karlsson FA. Effects of short-term administration of growth hormone in healthy young men, women, and women taking oral contraceptives. Journal of International Medicine 2000; 247: 570–578
  • Eng-Wong J, Hurstling SD, Venzon D, Perkins SN, Zujewski JA. Effect of raloxifene on insulin-like growth factor-1, insulin lie growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2003; 12: 1468–1473
  • Epstein SS. Unlabelled milk from cows treated with biosynthetic growth hormones: a case of regulatory abdication. International Journal of Health Services 1996; 26: 173–185
  • Ermis B, Altinkaynak K, Yildirim A, Ozkan B. Influence of smoking on serum and milk of mothers, and their infants’ serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels. Hormone Research 2004; 62: 288–292
  • Ernst M, Rodan GA. Estradiol regulation of insulin-like growth factor-1 expression in osteoblastic cells: evidence for transcriptional control. Molecular Endocrinology 1991; 5: 1081–1089
  • Evain-Brion D, Porquet D, Therond P, Fjellestad-Paulsen A, Greneche MO, Francois L, Czernichow P. Vitamin A deficiency and nocturnal growth hormone secretion in short children. Lancet 1994; 343: 87–88
  • Fafeur V, Gouin E, Dray F. Growth hormone-releasing factor (GRF) stimulates PGE2 production in rat anterior pituitary. Evidence for a PGE2 involvement in GRF-induced GH release. Biochemical and Biophysical Research Communications 1985; 126: 725–733
  • Ferraccioli G, Casatta L, Bartoli E. Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporine therapy. Journal of Rheumatology 1996; 23: 1539–1542
  • Ferraccioli G, Guerra P, Rizzi V, Bartoli E. Cyclosporin A increases somatomedin C insulin-like growth factor 1 levels in chronic rheumatic diseases. Journal of Rheumatology 1995; 22: 1060–1064
  • Ferraris JR, Pennisis P, Pasqualini T, Jasper H. Effects of deflazacort immunosuppression on long-term growth factors after renal transplantation. Paediatric Nephrology 1997; 11: 322–324
  • Finamor FE, Lengyel AM. Dexamethasone does not increase IGF-1 and IGFBP-3 levels in man in the absence of endogenous GH. Journal of Endocrinological Investigation 2001; 24: 871–875
  • Fisker S, Jorgensen JO, Val N, Orskov H, Christiansen JS. Impact of gender and androgen status on IGF-1 levels in normal and GH-deficient adults. European Journal of Endocrinology 1999; 141: 601–608
  • Forsling ML, Wheeler MJ, Williams AL. The effect of melatonin administration on pituitary hormone secretion in man. Clinical Endocrinology 1999; 51: 637–642
  • Forsyth IA, Wallis M. Growth hormone and prolactin — molecular and functional evolution. Journal of Mammary Gland Biology and Neoplasm 2002; 7: 291–312
  • Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, Jacobs C, Church D, Hassan AB. Insulin-like growth factor ligands, receptors, and binding proteins in cancer. Journal of Pathology 2005; 205: 145–153
  • Foy CG, Bell RA, Farmer DF, Goff DC, Jr, Wagenknecht LE. Smoking and incidence of diabetes among U.S. adults: finding from the Insulin Resistance Atherosclerosis Study. Diabetes Care 2005; 28: 2501–2507
  • Franklin M, Cowen PJ. Researching the antidepressant actions of Hypericum perforatum (St. John's Wort) in animals and man. Pharmacophyschiatry 2001; 34(Suppl. 1)S29–S37
  • Fredu PU, Reyes CM, Zuruzzaman AT, Sundeen RE, Khandji AG, Post KD. Cabergoline therapy of growth hormone and growth hormone/prolactin secreting pituitary tumours. Pituitary 2004; 7: 21–30
  • Frias J, Torres JM, Rodriguez R, Ruiz E, Ortega E. Effects of acute alcohol intoxication on growth axis in human adolescents of both sexes. Life Sciences 2000; 67: 2691–2697
  • Friedl A, Jordan VC, Pollak M. Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy. European Journal of Cancer 1993; 29A: 1368–1372
  • Frystyk J, Grofte T, Skjaerbaek C, Orskov H. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults. Journal of Clinical Endocrinology and Metabolism 1997; 82: 3124–3127
  • Fu Z, Noguchi T, Kato H. Differential regulation of IGFBP-2 and IGFBP-5-gene expression by vitamin A status in Japanese quail. American Journal of Physiology, Endocrinology and Metabolism 2001; 281: E138–E146
  • Fu Z, Yoneyama M, Noguchi T, Kato H. Response of the insulin-like growth factor system to vitamin A depletion and repletion in rats. Journal of Nutritional Science and Vitaminology 2002; 48: 453–460
  • Fujita-Yamaguchi Y, Kathuria S. Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potent inhibitor of insulin receptor than IGF-1 receptor. Biochemical and Biophysical Research Communications 1988; 157: 955–962
  • Gabbitas B, Canalis E. Retinoic acid regulates the expression of insulin-like growth factors 1 and 2 in osteoblasts. Journal of Cellular Physiology 1997; 172: 253–264
  • Gallardo-Williams MT, Chapin RE, King PE, Moser GJ, Goldsworthy TL, Morrison JP, Maronpot RR. Boron supplementation inhibits the growth and local expression of IGF-1 in human prostate adenocarcinoma (LNCaP) tumors in nude mice. Toxicologic Pathology 2004; 32: 73–78
  • Gamel-Didelon K, Corsi C, Pepeu G, Jung H, Gratzl M, Mayerhofer A. An autocrine role for pituitary GABA: activation of GABA-B receptors and regulation of growth hormone levels. Neuroendocrinology 2002; 76: 170–177
  • Ganmaa D, Sato A. The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Medical Hypotheses 2005; 65: 1028–1037
  • Gapstur SM, Kopp P, Chiu BU, Gann PH, Colangelo LA, Liu K. Longitudinal associations of age, anthropomorphic and lifestyle factors with serum total insulin-like growth factor-1 and IGF-binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study. Cancer Epidemiology, Biomarkers and Prevention 2004; 13: 2208–2216
  • Gatford KL, Egan AR, Clarke IJ, Owens PC. Sexual dimorphism of the somatotropic axis. Journal of Endocrinology 1998; 157: 373–389
  • Ge LH, Zhang WG, Shu R. A study of fluoride and dexamethasone affecting the expression of growth factors in osteoblast. Shanghai Journal of Stromatology 2001; 10: 336–338
  • Gebert CA, Park S, Waxman DJ. Down-regulation of liver JAK2-STAT5b signalling by the female plasma pattern of continuous growth hormone stimulation. Molecular Endocrinology 1999; 13: 213–227
  • Gelato MC, Oldfield E, Loriaux DL, Merriam GR. Pulsatile growth hormone secretion in patients with Acromegaly and normal men: the effects of growth hormone releasing hormone infusion. Journal of Clinical Endocrinology and Metabolism 1990; 71: 585–590
  • Genazzani AD, Stomati M, Strucchi C, Pucetti S, Luisi S, Genazzini AR. Oral Dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women. Fertility and Sterility 2001; 76: 241–248
  • Genazzani AR, Inglesse S, Lombardi I, Pieri M, Bernadi F, Genazzani AD, Rovati L, Luisi M. Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency. Aging Male 2004; 7: 133–143
  • Gerra G, Caccavari R, Fontanesi B, Marcato A, Fertonani G, Maestri D, Avanzini P, Lecchini R, Delsignore R, Mutti A. Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid. International Journal of Clinical Psychopharmacology 1994; 9: 211–215
  • Gianotti L, Arvat E, Valetto MR, Rammunni J, Di Vitro L, Maccagno B, Camanni F, Ghigo E. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa. Biological Psychiatry 1998; 43: 181–187
  • Gianotti L, Fassino S, Daga GA, Lanfranco F, De Bacco C, Ramunni J, Arvat E, MacCario M, Ghigo E. Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa. Clinical Endocrinology 2000; 52: 713–720
  • Gibson GG, Skett P. Introduction to drug metabolism. Nelson Thornes Ltd., CheltenhamUK 2001; 87–118
  • Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review. Cancer Causes and Control 2005; 16: 83–95
  • Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB, Willett WC. Nutritional predictors of insulin-like growth factor 1 and their relationships to cancer in men. Cancer Epidemiology, Biomarkers and Prevention 2003; 12: 84–89
  • Giusi G, Facciolo RM, Canonaco M, Alleva E, Belloni V, Dessi-Fulgheri F, Santucci D. The endocrine disruptor atrazine accounts for a dimorphic somatostatinergic neuronal expression pattern in mice. Toxicological Sciences 2005; 89: 257–264
  • Giustina A, Bussi AR, Doga M, Licini M, Schettino M, Wehrenberg WB. Effects of metoclopramide on the growth hormone response to galanin in normal men. Hormone and Metabolic Research 1993; 25: 489–492
  • Giustina A, Desenzani P, Scalvini T. Impact of testosterone replacement on the maturation of the growth hormone-IGF-1 axis. Sex steroid interactions with growth hormone, JD Veldhuis, A Giustina. Springer Verlag, New York 1999; 20–31
  • Giustina A, Malerba M, Bresciani E, Desnzani P, Licini M, Zaltieri G, Grassi V. Effect of two beta 2-agonist drugs, Salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis. Journal of Endocrinological Investigation 1995; 18: 847–852
  • Glintborg D, Stoving RK, Hagen C, Hermann AP, Frystyk J, Veldhuis JD, Flyvbjerg A, Andersen M. Pioglitazone treatment increases spontaneous growth hormone secretion and stimulated growth hormone levels in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2005; 90: 5605–5612
  • Goebel MU, Baase J, Pithan V, Exton M, Saller B, Schedlowski M, Limmroth V. Acute interferon beta-1b administration alters hypothalamic–pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects. Psychneuroendocrinology 2002; 27: 881–892
  • Gohlke BC, Fahnenstich H, Dame C, Albers N. Longitudinal data for intraueterine levels of fetal IGF-1 and IGF-2. Hormone Research 2004; 61: 200–204
  • Goldbloom DS, Garfinkel PE, Katz R, Brown GM. The hormonal response to intravenous 5-hydroxytryptophan in bulimia nervosa. Journal of Psychosomatic Research 1996; 40: 289–297
  • Goldstein D, Gockerman J, Krishnan R, Ritchie J, Jr, Tso CY, Hood LE, Ellinwood E, Laszlo J. Effects of gamma-interferon on the endocrine system: results from a phase 1 study. Cancer Research 1987; 47: 6397–6401
  • Gong H, Xie W. Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential. Expert Opinion on Therapeutic Targets 2004; 8: 49–54
  • Gooch JL, Tang Y, Ricono JM, Abboud HE. Insulin-like growth factor-1 induces renal cell hypertrophy via a calcineurin-dependent mechanism. Journal of Biological Chemistry 2001; 276: 492–500
  • Goossens K, Esquent M, Swinnen JV, Manin M, Rombauts W, Verhoeven G. Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNcaP prostatic adenocarcinoma cells. Molecular and Cellular Endocrinology 1999; 155: 9–18
  • Gosiewska A, Wilson S, Kwon D, Peterkofsky B. Evidence for an in vivo role of insulin-like growth factor-binding protein-1 and -2 as inhibitors of collagen gene expression in vitamin C-deficient and fasted guinea pigs. Endocrinology 1994; 134: 1329–1339
  • Gould JC, Cooper KR, Scanes CG. Effects of polychlorinated biphenyl mixtures and three specific congeners on growth and circulating growth-related hormones. General and Comparative Endocrinology 1997; 106: 221–230
  • Greschik H, Moras D. Structure–activity relationship of nuclear receptor–ligand interactions. Current Topics in Medicinal Chemistry 2003; 3: 1573–1599
  • Gromova EG, Sviridova SP, Kushlinskii NE, Larionova VB, Shishkin MN. Regulation of the indices of neuroendocrine status in surgical patients with lung cancer using optimal doses of ascorbic acid. Anesteziologica Reanimatologica 1990; 5: 71–74
  • Gronbaek H, Flyvberg A, Winding P, Frystk J, Hey H. Effects of pure ethanol and alcopops on glucose, insulin, and the insulin-like growth factor system in healthy subjects. Growth Hormone and IGF Research 2005; 15: 243–250
  • Gronbaek H, Skjaerbaek C, Orskov H, Flyvberg A. Effect of immunosuppression on kidney and serum insulin-like growth factor-1 (IGF-1), IGF binding proteins, and renal growth following unilateral nephrectomy in rats. Metabolism 1998; 47: 817–823
  • Grottoli S, Gasco V, Ragazzoni F, Ghigo E. Hormonal diagnosis of GH hypersecretory states. Journal of Endocrinological Investigation 2003; 26(10 Suppl.)27–35
  • Grounds MD. Reasons for the degeneration of ageing skeletal muscle: central role for IGF-1 signalling. Biogerontology 2002; 3: 19–24
  • Guibourdenche J, Djakoure C, Porquet D, Pagsey P, Rochette-Egly C, Peillon F, Li JY, Evain-Brion D. Retinoic acid stimulates growth hormone synthesis in human somatotropic adenoma cells: characterization of its nuclear receptors. Journal of Cellular Biochemistry 1997; 65: 25–31
  • Gunnell D, Oilver SE, Peters TJ, Donovan JL, Persad R, Maynard M, Gillatt D, Pearce A, Hamdy FC, Neal DE, Holly JMP. Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-1 and IGFBP-3 in healthy middle-aged men. British Journal of cancer 2003; 8: 1682–1686
  • Guo L, Zhao YY, Dong LY, Ding Q, Sun KL, Ji SJ, Wang LZ. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the gene expression of insulin-like growth factors family in osteoblast cells. Chinese Journal of Medical Genetics 2003; 20: 490–494
  • Guo L, Zhao YY, Ji SJ, Sun KL, Dong LY. Effect of the regulation of IGFs system components in retinoic acid-induced congenital clubfoot. ACTA Genetica Sinicia 2004; 31: 766–770
  • Haase H, Maret W. Fluctuation of cellular, available zinc modulate insulin signalling via inhibition of protein tyrosine phosphatases. Journal of Trace Elements in Medicine and Biology 2005; 19: 37–42
  • Hall K, Hilding A, Thoren M. Determinants of circulating insulin-like growth factor-1. Journal of Endocrinological Investigation 1999; 22(5 Suppl.)48–57
  • Hanaire-Broutin H, Sallerin-Coute B, Poncet MF, Tauber M, Bastide R, Chale JJ, Rosenfeld R, Taubler JP. Effect of intraperitoneal ensulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-1, and IGF-binding protein-3 ni IDDM. Diabetologia 1996; 39: 1498–1504
  • Hanew K, Utsumi A. The role of endogenous GHRH in arginine-, insulin-, clonidine- and L-dopa-induced GH release in normal subjects. European Journal of Endocrinology 2002; 146: 197–202
  • Hansen TK, Moller J, Thomsen K, Frandsen E, Dall R, Jorgenssen JO, Christiansen JS. Effects of growth hormone on renal handling of sodium in healthy humans. American Journal of Physiology, Endocrinology and Metabolism 2001; 281: E1326–E1332
  • Harada T, Yamauchi T, Tsukanaka A, Matsumura Y, Kurono M, Honda A, Matsui N. Involvement of muscarinic cholinergic and alpha2-adrenergic mechanisms in growth hormone secretion during exercise in humans. European Journal of Applied Physiology 2000; 83: 268–273
  • Hashiguchi Y, Molina PE, Fan J, Lang CH, Abumrad NN. Central opiate modulation of growth hormone and insulin-like growth factor-I. Brain Research Bulletin 1996; 40: 99–104
  • Hathaway MR, Dayton WR, White ME, Henderson TL, Young DA, Doan TN. Effect of feed intake on antimicrobially induced increases in porcine serum insulin-like growth factor I. Journal of Animal Science 1999; 77: 3208–3214
  • Hawkins M, Barzilai N, Chen W, Angelov I, Hu M, Cohen P, Rossetti L. Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes 1996; 45: 1734–1743
  • Heaney RP, McCarron DA, Dawson-Hughes B, Oparil S, Berga SL, Stern JS, Barr SI, Rosen CJ. Dietary changes favourably affect bone remodelling in older adults. Journal of the American Dietetic Association 1999; 99: 1228–1233
  • Hehenberger K, Hansson A. High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochemistry and Function 1997; 15: 197–201
  • Helle SI, Ekse D, Holly JM, Lonning PE. The IGF-system ni healthy pre- and postmenopausal women: relations to demographic variables and sex steroids. Journal of Steroid Biochemistry and Molecular Biology 2002; 81: 95–102
  • Henrohn D, Le P, Nyberg F. Morphine alters the levels of growth hormone receptor mRNA and [125I]growth hormone binding in human IM-9 lymphoblasts via a naloxone-reversible mechanism. Molecular and Cellular Endocrinology 1997; 135: 147–152
  • Hernandez J, Syed S, Weiss G, Fernaddes G, Von D, Troyer DA, Basler JW, Thompson IM, Jr. The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial. Journal of Urology 2005; 174: 519–522
  • Herzog A, Siler U, Spitzer V, Seifert N, Denelavas A, Hunziker PB, Hunziker W, Goraleczyk R, Wertz K. Lucopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate. FASEB Journal 2005; 19: 272–274
  • Hilding A, Hall K, Skogsberg J, Ehrenborg E, Lewitt MS. Troglitazone stimulates IGF-binding protein-1 by a PPAR gamma-independent mechanism. Biochemical and Biophysical Research Communications 2003; 303: 693–699
  • Hirschowitz J, Hitzemann R, Burr G, Schwartz A. A new approach to dose reduction in chronic schizophrenia. Neuropsychopharmacology 1991; 5: 103–113
  • Ho KK, O'Sullivan AJ, Weissberger AJ, Kelly JJ. Sex steroid regulation of growth hormone secretion and action. Hormone Research 1996; 45: 67–73
  • Hochberg Z. Mechanisms of steroid impairment of growth. Hormone Research 2002; 58(Suppl 1)33–38
  • Hoeck HC, Jakobsen PE, Vestergaard P, Falhof J, Laurberg P. Differences in reproducibility and peak growth hormone responses to repeated testing with various stimualtors in healthy adults. Growth Hormone and IGF Research 1999; 9: 18–24
  • Hoffman AR. Treatment of the adult growth hormone deficiency syndrome: directions for future research. Growth Hormone and IGF Research 2005; 15(Suppl. A)48–52
  • Holt RI. Fetal programming of the growth hormone–insulin-like growth factor axis. Trends in Endocrinology and Metabolism 2002; 13: 392–397
  • Holt RI, Simpson HL, Sonksen PH. The role of the growth hormone–insulin-like growth factor axis in glucose homeostasis. Diabetic Medicine 2003; 20: 3–15
  • Hong C, Tang B, Hammond GL, Tritchler D, Yaffe M, Boyd NF. Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study. Breast Cancer Research 2004; 6: R352–R365
  • Huang SS, Huang JS. TGF-beta control of cell proliferation. Journal of Cellular Biochemistry 2005; 96: 447–462
  • Huseman CA, Varma MM, Angle CR. Neuroendocrine effects of toxic and low blood lead levels in children. Pediatrics 1992; 90: 186–189
  • Hussain M, Banerjee M, Sarkar FH, Djuric Z, Pollak MN, Doerge D, Fontana J, Chinni S, Davis J, Forman J, Wood DP, Kucuk O. Soy isoflavone in the treatment of prostate cancer. Nutrition and Cancer 2003; 47: 111–117
  • Huynh H, Nickerson T, Pollak M, Yang X. Regulation of the insulin-like growth factor 1 receptor expression by the pure antiestrogen ICI182780. Clinical Cancer Research 1996; 2: 2037–2042
  • Hwa V, Little B, Kofoed EM, Rosenfeld RG. Transcriptional regulation of insulin-like growth factor-1 by interferon-gamma requires STAT-5b. Journal of Biological Chemistry 2004; 279: 2728–2736
  • Hwang ES, Bowen PE. Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells. Biofactors 2005; 23: 97–105
  • Iglesias P, Bayon C, Mendez J, Gancedo PG, Grande C, Diez JJ. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction. Thyroid 2001; 11: 1043–1048
  • Imamoglu S, Bereket A, Turan S, Taga Y, Haklar G. Effect of zinc supplementation on growth hormone secretion, IGF-1, IGFBP-3, sommatomedin generation, alkaline phosphatase, osteocalcin and growth in prepubertal children with idiopathic short stature. Journal of Pediatric Endocrinology and Metabolism 2005; 18: 69–74
  • Ingraham HA, Redinbo MR. Orphan nuclear receptors adopted by crystallography. Current Opinion in Structural Biology 2005; 15: 708–715
  • Ivesmaki V, Jaattela M, Saksela E, Voutilainen R. Tumor necrosis factor-alpha and interferon-gamma inhibit insulin-like growth factor 2 gene expression in human fetal adrenal cell cultures. Molecular and Cellular Endocrinology 1993; 91: 59–65
  • Izquierdo-Claros RM, Boyano-Adanez M del C, Arilla-Ferreiro E. Activity of the hippocampal somatostatinergic system following daily administration of melatonin. Brain Research. Brain Molecular Research 2004; 126: 107–113
  • Jacobs CM, Paulsen RE. Crosstalk between ERK2 and RXR regulates nuclear import of transcription factor NGFI-B. Biochemical and Biochemical Research Communications 2005; 336: 646–652
  • Jalil JE, Ebensperger R, Melendez J, Acevedo E, Sapag-Hagar M, Gonzalez-Jara F, Galvez A, Perez-Montes V, Lavandero S. Effects of antihypertensive treatment on cardiac IGF-1 during prevention of ventricular hypertrophy in the rat. Life Sciences 1999; 64: 1603–1612
  • Jansson JO, Ekberg S, Isaksson O, Mode A, Gustafsson JA. Imprinting of growth hormone secretion, body growth, and hepatic steroid metabolism by neonatal testosterone. Endocrinology 1985; 117: 1881–1889
  • Jasper H, Cassinelli H. Growth hormone and insulin-like growth factor 1 plasma levels in patients with hypophosphatemic rickets. Journal of Pediatric Endocrinology 1993; 6: 179–184
  • Jehle PM, Jehle DR, Mohan S, Bohm BO. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients. Journal of Endocrinology 1998; 159: 297–306
  • Jenkins PJ. Acromegaly and cancer. Hormone Research 2004; 62(Suppl. 1)408–415
  • Jimeno L, Rodado R, Barrios Y, Campos M, Llorente S, Nicolas F, Mingueala A. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with post-transplantation erythrocytosis. Transplantation Proceedings 2005; 37: 1012–1013
  • Johansson S, Fredholm BB, Hjort C, Morein T, Kull B, Hu PS. Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor. Biochemical Pharmacology 2005; 70: 598–605
  • Johnson DW, Saunders HJ, Johnson FJ, Huq SO, Field MJ, Pollack CA. Cyclosporin exerts a direct fibrogeneic effect on human tubulointerstital cells: roles of insulin-like growth factor 1, transforming growth factor beta1 and platelet derived growth factor. Journal of Pharmacology and Experimental Therapeutics 1999; 289: 535–542
  • Johnson JD, Chang JP. Calcium buffering activity of mitochondria controls basal growth hormone secretion and modulates specific neuropeptide signalling. Cell Calcium 2005; 37: 573–581
  • Jones S, Burt BA, Petersen PE, Lennon MA. The effective use of fluorides in public health. Bulletin of the World Health Organisation 2005; 83: 670–676
  • Jorgensen EH, Aas-Hansen O, Maule AG, Strand JE, Vijayan MM. PCB impairs smoltification and seawater performance in anadromous Artic charr (Salvelinus alpinus). Comparative Biochemistry and Physiology. Toxicology and Pharmacology 2004; 138: 203–212
  • Jousse C, Averous J, Bruhat A, Carraro V, Mordier S, Fafournoux P. Amino acids as regulators of gene expression: molecular mechanisms. Biochemical and Biophysical Research Communications 2004; 313: 447–452
  • Jurgens G, Lange KH, Reuther LO, Rasmussen BB, Brosen K, Christenses HR. Effect of growth hormone on hepatic cytochrome P450 activity in healthy elderly men. Clinical Pharmacology and Therapeutics 2002; 71: 162–168
  • Juul A, Scheike T, Neilson CT, Krabbe S, Muller J, Skakkebaek NE. Serum insulin-like growth factor 1 (IGF-1) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotrophin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). Journal of Clinical Endocrinology and Metabolism 1995; 80: 3059–3067
  • Kajdaniuk D, Marek B. Influence of adjuvant chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil on plasma insulin-like growth actor-1 and chosen hormone in breast cancer pre-menopausal patients. Journal of Clinical Pharmacy and Therapeutics 2000; 25: 67–72
  • Kaklamani VG, Linos A, Kaklamani E, Markaki I, Koumantaki Y, Mantzoros CS. Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. Journal of Clinical Oncology 1999a; 17: 3291–3298
  • Kaklamani VG, Linos A, Kaklamani E, Markaki I, Mantzoros C. Age, sex and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. Journal of Clinical Oncology 1999b; 17: 813–817
  • Kanbur-Oksuz N, Derman O, Kinik E. Correlation of sex steroids with IGF-1 and IGFBP-3 during different pubertal stages. Turkish Journal of Paediatrics 2004; 46: 315–321
  • Kang JX, Li Y, Leaf A. Mannose-6-phosphate/insulin-like growth factor-2 receptor is a receptor for retinoic acid. Proceedings of the National Academy of Sciences, USA 1997; 94: 13671–13676
  • Kao YJ, Hiipakka RA, Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 2000; 141: 980–987
  • Karas M, Amir H, Fishman D, Danilekno M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J, Sharoni Y. Lycopene interferes with cell cycle progression and insulin-like growth factor 1 signalling in mammary cancer cells. Nutrition and Cancer 2000; 36: 101–111
  • Kato Y, Murakami Y, Sohmiya M, Nishiki M. Regulation of human growth hormone secretion and its disorders. International Medicine 2002; 41: 7–13
  • Kaur R, Naspal JK, Das BR. Polymorphism in IGF-2 as a surrogate marker for predisposition towards tobacco chewing-mediated oral cancer. Tumour Biology 2005; 26: 147–152
  • Kerr D, Sherwin RS, Pavalkis F, Fayard PB, Sikorski L, Rife F, Tamborlane WV, During MJ. Effect of caffeine on the recognition of and responses to hypoglycaemia in humans. Annals of Internal Medicine 1993; 119: 799–804
  • Khalil DA, Lucas EA, Juma S, Smith BJ, Payton ME, Arjmandi BH. Soy protein supplementation increases serum insulin-like growth factor-1 in young and old men but does not affect markers of bone metabolism. Journal of Nutrition 2002; 132: 2605–2608
  • Kim DG, Lee DY, Cho BH, You KR, Kim MY, Ahn DS. Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid. Hepatology 1999; 29: 1091–1098
  • Kim EJ, Kang YH, Schaffer BS, Bach LA, MacDonald RG, Park JH. Inhibition of Caco-2 cell proliferation by all-trans retinoic acid: role of insulin-like growth factor binding-protein-6. Journal of Cellular Physiology 2002; 190: 92–100
  • Kimber J, Sivenandan M, Watson I, Mathias CJ. Age- and gender-related growth hormone responses to intravenous clonidine in healthy adults. Growth Hormone and IGF Research 2001; 11: 128–135
  • Klein RD, Fischer SM. Black tea polyphenols inhibit IGF-1 induced signalling through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells. Carcinogenesis 2002; 23: 217–221
  • Kobayashi K, Amemiya S, Kobayashi K, Sawanobori E, Mochizuki M, Ishihara T, Higashida K, Miura M, Nakazawa S. The involvement of growth-hormone binding-protein in altered GH–IGF axis in IDDM. Endocrine Journal 1999; 46(Suppl.)S67–S69
  • Kohn B, Julius JR, Blethen SL. Combined use of growth hormone and gonadotrophin-releasing hormone analogues: the national cooperative growth study experience. Pediatrics 1999; 104: 1014–1048
  • Kok P, Madelon MB, Kok SW, Van IHAP, Frolich M, Roelfsema F, Voshol PJ, Meinders AE, Pijl H. Acipimox enhances spontaneous growth hormone secretion in obese women. American Journal of Physiology 2003; 286: 793–798
  • Kotokorpi P, Gardmo C, Nystrom CS, Mode A. Activation of the glucocorticoid receptor or liver X receptors interferes with growth hormone-induced aKr1b7 gene expression in rat hepatocytes. Endocrinology 2004; 145: 5704–5713
  • Krassas GE. Somatostatin analogs: a new tool for the management of Graves’ ophthalmopathy. Journal of Endocrinological Investigation 2004; 27: 281–287
  • Krystal JH, Woods SW, Levesque M, Heninger C, Heninger GR. The effects of carbon dioxide on plasma MHPG, plasma hormone respiratory rate, and behaviour in the rhesus monkey. Life Sciences 1989; 45: 4657–4663
  • Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MM, Khachik F, Banerjee M, Bertram JS, Wood DP, Jr. Effects of lycopene supplementation in patients with localized prostate cancer. Experimental Biological Medicine 2002; 227: 881–885
  • Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khchik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP, Jr. Phase 2 randomized clinical trial f lycopene supplementation before radical prostatectomy. Cancer Epidemiology, Biomarkers and Prevention 2001; 10: 861–868
  • Kumar V, Silvis C, Nystrom G, Deshpande N, Vary TC, Frost RA, Lang CH. Alcohol-induced increases in insulin-like growth factor binding protein-1 are partially mediated by TNF. Alcoholism, Clinical and Experimental Research 2002; 26: 1574–1583
  • Laakmann G, Zygan K, Schoen HW, Weiss A, Wittmann M, Neissner R, Blaschke D. Effect of receptor blockers (methysergide, propanolol, phentolamine, yohimbine and prazosin) on desimipramine induced pituitary hormone stimulation in humans 1 — growth hormone. Psychoneuroendocrinology 1986; 11: 447–461
  • Laatikainen T, Anttila L, Suikkari AM, Ruutiainen K, Erkkola R, Seppala M. Effect of naloxone on plasma insulin, insulin-like growth factor I, and its binding protein 1 in patients with polycystic ovarian disease. Fertility and Sterility 1990; 54: 434–437
  • Laban C, Bustin SA, Jenkins PJ. The GH–IGF-1-axis and breast cancer. Trends in Endocrinology and Metabolism 2003; 14: 28–34
  • Lago F, Gonzalez-Juanatey JR, Casanueva FF, Gomez-Reino J, Dieguez C, Gualillo O. Ghrelin, the same peptide for different functions: player or bystander? Vitamins and Hormones 2005; 71: 405–432
  • Lagopoulos L, Sunahara GI, Wurzner H, Fliesen T, Stalder R. The correlation of body growth with diethylnitrosamine-induced hepatocarcinogenesis in relation to serum insulin and somatomedin-C. Carcinogenesis 1991; 12: 211–215
  • Lal S, Thavunayil JX, Krishnan B, Nair NP, Schwartz G, Guyda H. The effect of yohimbine, an alpha2 adrenergic receptor antagonist, on the growth hormone response to apomorphone in normal subjects. Journal of Psychiatry and Neuroscience 1996; 21: 96–100
  • Lamarthiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. Journal of Nutrition 2002; 132: 552S–555S
  • Lambert HW, Weiss ER, Launder JM. Activation of 5-HT receptors that stimulate the adenyl cyclase pathway positively regulates IGF-1 in cultured craniofacial mesenchymal cells. Developmental Neuroscience 2001; 23: 70–77
  • Landin-Wilhelmsen K, Lunberg P, Lappas G, Wilhelmsen L. Insulin-like growth factor 1 levels in healthy adults. Hormone Research 2004; 62(Suppl. 1)8–16
  • Lands WE. Alcohol, slow wave sleep, and the somatotropic axis. Alcohol 1999; 18: 109–122
  • Larsson SC, Wolk K, Brismar K, Wolk A. Association of diet with serum insulin-like growth factor 1 in middle-aged and elderly men. American Journal of Clinical Nutrition 2005; 81: 1163–1167
  • Las W, Hiney JK, Srivastava V. Alcohol's effects on female puberty: the role of insulin-like growth factor-1. Alcohol Health and Research World 1998; 22: 165–169
  • Lasa M, Chiloeches A, Garcia N, Montes A, Toro MJ. Lovastatin decreases prolactin and growth hormone gene expression in GH4C1 cell through a cAMP dependent mechanism. Molecular and Cellular Endocrinology 1997; 130: 93–100
  • Lau KH, Goodwin C, Arias M, Mohan S, Baylink DJ. Bone cell mitogenic action of fluoraluminate and aluminium fluoride but not that of sodium fluoride involves upregulation of the insulin-like growth factor system. Bone 2002; 30: 705–711
  • Lavigne JA, Baer DJ, Wombrow HH, Albert PS, Brown ED, Judd JT, Campbell WS, Giffeb CA, Dorgan JF, Hartman TJ, Barrett JC, Hursting SD, Taylor PR. Effects of alcohol on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women. American Journal of Clinical Nutrition 2005; 81: 503–507
  • Lavigne JA, Wimbrow HH, Clecidence BA, Albert PS, Reichman ME, Campbell WS, Barrett JC, Hurstling SD, Judd JT, Taylor PR. Effects of alcohol and menstrual cycle on insulin-like growth factor-1 and insulin-like growth factor binding protein-3. Cancer Epidemiology, Biomarkers and Prevention 2004; 13: 2264–2267
  • Law BK, Waltner-Law ME, Entingh AJ, Chytil A, Aakre ME, Norgaard P, Moses HL. Salicylate-induced growth arrest is associated with inhibition of P70s6k and down-regulation of c-myc, cyclin D1, cyclin A, and proliferating cell nuclear antigen. Journal of Biological Chemistry 2000; 275: 38261–38267
  • Lawrence JB, Conover CA, Haddad TC, Ingle JN, Reid JM, Ames MM, Suman VJ, Marks RS, Erlichman C, Hartmann LC. Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins. Clinical Cancer Research 1997; 3: 1713–1720
  • Le Roith D, Bondy C, Yakar S, Liu J, Butler A. The somatomedin hypothesis: 2001. Endocrine Reviews 2001; 22: 53–74
  • Leach RM, Forsling ML. The effect of changes in arterial PCO2 on neuroendocrine function in man. Experimental Physiology 2004; 89: 287–292
  • Lee HY, Chang YS, Han JY, Liu DD, Lee JJ, Lotan R, Spitz MR, Hong WK. Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers. Journal of Clinical Oncology 2005b; 23: 4439–4449
  • Lee KW, Cohen P. Nuclear effects: unexplained intracellular actions of insulin-like growth factor binding protein-3. Journal of Endocrinology 2002; 175: 33–40
  • Lee KW, Ma L, Yan X, Liu B, Zhang XK, Cohen P. Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77. Journal of Biological Chemistry 2005a; 280: 16942–16948
  • Lehmann R, Wagner JL, Fernandez LA, Bourgoignie JJ, Ricordi C, Alejandro R, Kenyon NS. Effects of ketamine sedation on glucose clearance, insulin secretion and counterregulatory hormone production in baboons (Papio hamadryas). Journal of Medical Primatology 1997; 26: 312–321
  • Leitzmann ME, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL. Zinc supplement use an risk of prostate cancer. Journal of the National Cancer Institute 2003; 95: 1004–1007
  • Les Dees W, Hiney JK, Srivastava V. Alcohol's effects on female puberty: The role of insulin-like growth factor 1. Alcohol Health and Research World 1998; 22: 165–169
  • Leung KC, Johannsson G, Leong GM, Ho KK. Estrogen regulation of growth hormone action. Endocrinology Reviews 2004; 25: 693–721
  • Li W, Trovero F, Cordier J, Wang Y, Drieu K, Papadopoulos V. Prenatal exposure of rats to Ginkgo biloba extract (Egb761) increases neuronal survival/growth and alters gene expression in the developing fetal hippocampus. Brain Research. Developmental Brain Research 2003; 144: 169–180
  • Lian F, Chung J, Russell RM, Wang XD. Alcohol-reduced plasma IGF-1 levels and hepatic IGF-1 expression can be partially restored by retinoic acid supplementation in rats. Journal of Nutrition 2004; 134: 2953–2956
  • Liao W, Rudling M, Moller C, Angelin B. Endogenous histamine reduces plasma insulin-like growth factor 1 via H1 receptor-mediated pathway in rat. European Journal of Pharmacology 1999; 374: 471–476
  • Lintelmann J, Katayama A, Kurihara N, Shore L, Wenzel A. Endocrine disruptors in the environment (IUPAC technical report). Pure and Applied Chemistry 2003; 75: 631–681
  • Lissett CA, Shalet SM. The impact of dose and route of estrogen administration on the somatotropic axis in normal women. Journal of Clinical Endocrinology and Metabolism 2003; 88: 4668–4672
  • Lissett CAM, Gleeson H, Shalet SM. The insulin-like growth factor 1 generation test in adults. Hormone Research 2004; 62(Suppl. 1)44–49
  • Liu C, Jian F, Smith DE, Russell RM, Wang X. Lycopene supplementation inhibits lung squamous metaplasia ad induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Research 2003; 63: 3138–3144
  • Liu H, Biegel L, Narasimhan TR, Rowlands C, Safe S. Inhibition of insulin-like growth factor-1 responses in MCF-7 cells by 2,3,7,8-tetrachloro-p-dioxin and related compounds. Molecular and Cellular Endocrinology 1992; 87: 19–28
  • Lloyd RV, Jin L, Tsumanuma I, Vidal S, Kovacs K, Horvath E, Scheithauer BW, Couce ME, Burguera B. Leptin and leptin receptor in anterior pituitary function. Pituitary 2001; 4: 33–47
  • Loche S, Puggioni R, Fanni T, Cella SG, Muller EE, Pintor C. Augmentation of growth hormone secretion in children with constitutional growth delay by sort-term clonidine administration: a pulse amplitude-modulated phenomenon. Journal of Clinical Endocrinology and Metabolism 1989; 68: 426–430
  • Lopez-Calderon A, Soto L, Villanua MA, Vidarte L, Martin AI. The effect of cyclosporine administration on growth hormone release and serum concentrations of insulin-like growth factor-1 in male rats. Life Sciences 1999; 64: 1473–1483
  • Losa M, Huss R, Konig A, Muller OA, Von Werder K. Theophylline blunts the GH-response to growth hormone releasing hormone in normal subjects. Acta Endocrinologica 1986; 112: 473–480
  • Lovejoy JC, Smith SR, Bray GA, Veldhuis JD, Rood JC, Tulley R. Effects of experimentally induced mild hyperthyroidism on growth hormone and insulin secretion and sex steroid levels in healthy young men. Metabolism 1997; 43: 1424–1428
  • Luger TJ, Fassler R, Gottardis M, Koller W, Mutz N. Behavior of hGH (human growth hormone) and somatomedin C following anaesthesia induction with propofol in comparison with diazepam and thiopental. Anasthesie. Intensivetherapie, Notfallmedizin 1989; 24: 226–230
  • Lukanova A, Toniolo P, Akhemdkhanov A, Hunt K, Rinaldi S, Zeleniuch-Jacquotte A, Haley NJ, Riboli E, Stattin P, Lundin E, Kaaks R. A cross-sectional study of IGF-1 determinants in women. European Journal of Cancer Prevention 2001; 10: 443–452
  • Luo G, Yu-Lee L. Stat5b inhibits NFkB-mediated signalling. Molecular Endocrinology 2000; 14: 114–133
  • Ma J, Giovannucci E, Pollak M, Chan JM, Gaziano JM, Willett W, Stampfer MJ. Milk intake, circulating levels of insulin-like growth factor-1, and risk of colorectal cancer in men. Journal of the National Cancer Institute 2001; 93: 1330–1337
  • MacDonald RS. The role of zinc in growth and cell proliferation. Journal of Nutrition 2000; 130(5s Suppl.)1500S–1508S
  • Maitre M, Humbert JP, Kemmel V, Aunis D, Andriamampandry C. A mechanism for gamma-hysroxybutyrate (BHB) as a drug and substance of abuse. Medical Science 2005; 21: 284–289
  • Malatinsky J, Vigas M, Jurcovicova J, Jezova D, Garayova S, Minarikova M. The patterns of endocrine response to surgical stress during different types of anesthesia and surgery in man. Acta Anaesthesiolica Belgica 1986; 37: 23–32
  • Mallo F, Lamas JA, Casanueva FF, Dieguez C. Effect of retinoic acid deficiency on in vivo and in vitro GH responses to GHRH in male rats. Neuroendocrinology 1992; 55: 642–647
  • Mandala M, Moro C, Ferretti G, Calabro MG, Nole F, Rocca A, Munzone E, Castro A, Curigliano G. Effect of tamoxifen on GH and IGF-1 serum level in stage 1–2 breast cancer patients. Anticancer Research 2001; 21(1B)585–588
  • Manner T, Kanto J, Ruskaho H, Karhuvaara S, Viinamake O, Valimaki M, Scheinin M. Hormonal, haemodynamic and subjective effects of intravenously infused indomethacin: no change in the physiological response to hypertonic saline challenge. Pharmacology and Toxicology 1989; 65: 231–235
  • Marana E, Annetta MG, Meo F, Parpaglioni R, Galeone M, Maussier ML, Marana R. Sevoflurane improves the neuroendocrine stress response during laparoscopic pelvic surgery. Canadian Journal of Anaesthesiology 2003; 50: 348–354
  • Martignoni E, Horowski R, Liuzzi A, Costa A, Dallabonanza D, Cozzi R, Attanasio R, Rainer E, Nappi G. Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo. Clinical Neuropharmacology 1996; 19: 72–80
  • Martinetti A, Ferrari L, Celio L, Mariani L, Miceli R, Zilembo N, Di Bartolomeo M, Toffolatti L, Pozzi P, Seregni E, Bombardieri E, Bajetti E. The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: Effects on bone metabolism markers. Journal of Steroid Biochemistry and Molecular Biology 2000; 75: 65–73
  • Marzouk HF, Hofland LJ, Den Holder FH, Van Koetsveld PM, Steenbergen J, Zuiderwijk J, Abou-Hashim EM, el-Kannishy MH, De Jong FH, Lamberts SW. Effects of suramin on hormone release by cultures rat anterior pituitary cells. Molecular and Cellular Endocrinology 1990; 72: 95–102
  • Maskarinec G, Takata Y, Kaaks R. The relation between nutritional factors and insulin-like growth factor-1 in premenopausal women of different ethnicity. European Journal of Nutrition 2005; 44: 105–113
  • Matilainen M, Malinen M, Saavalainen K, Carlberg C. Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Research 2005; 33: 5521–5532
  • Matsumura A, Ghosh A, Pope GS, Darbre PD. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 2005; 94: 431–443
  • Mauras N, Haymond MW. Are the metabolic effects of GH and IGF-1 separable? Growth Hormone and IGF Research 2005; 15: 19–27
  • McCarty MF. IGF-1 activity may be a key determinant of stroke risk — a cautionary tale for vegans. Medical Hypotheses 2003; 61: 323–334
  • McCusker RH, Novakofski J. Zinc partitions IGFs from soluble IGF binding proteins (IGFBP)-5 but not soluble IGFBP-4, to myblast IGF type 1 receptors. Journal of Endocrinology 2004; 180: 227–246
  • Meeking DR, Wallace JD, Cuneo RC, Forsling M, Russell-Jones DL. Exercise-induced GH secretion is enhanced by the oral ingestion of melatonin in healthy male subjects. European Journal of Endocrinology 1999; 141: 22–26
  • Mehls O, Himmele R, Homme M, Kiepe D, Klaus G. The interaction of glucocorticoids with the growth hormone–insulin-like growth factor axis and its effects on growth plate chondrocytes and bone cells. Journal of Paediatric Endocrinology and Metabolism 2001; 14(Suppl. 6)1475–1482
  • Mendelson WB, Lantigua RA, Wyatt RJ, Gillin JC, Jacobs LS. Piperidine enhances sleep-related and insulin-induced growth hormone secretion: further evidence for a cholinergic secretory mechanism. Journal of Clinical Endocrinology and Metabolism 1981; 52: 409–415
  • Mertes N, Goeters C, Kuhmann M, Zander JF. Postoperative α2-adrenergic stimulation attenuates protein catabolism. Anaesthesia and Analgesia 1996; 82: 258–263
  • Mesotten D, Wouter S, Peeters RP, Hardman KV, Holly JM, Baxter RC, Van der Berghe G. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. Journal of Clinical Endocrinology and Metabolism 2004; 89: 3105–3113
  • Metzger DL, Kerrigan JR. Sex steroid-hormone modulation of the somatotropic axis during normal male puberty. Sex steroid interactions with growth hormone, JD Veldhuis, A Giustina. Springer Verlag, New York 1999; 32–43
  • Michael LF, Schkeryantz JM, Burris TP. The pharmacology of LXR. Mini Reviews in Medicinal Chemistry 2005; 5: 729–740
  • Michelson D, Amsterdam J, Apter J, Fava M, Londborg P, Tamura R, Pagh L. Hormonal markers of stress response following interruption of selective serotonin re-uptake inhibitor treatment. Psychoneuroendocrinology 2000; 25: 169–177
  • Miglietta L, Barreca A, Repetto L, Constantini M, Rosso R, Boccardo F. Suramin and serum insulin-like growth factor levels in metastatic cancer patients. Anticancer Research 1993; 13: 2473–2476
  • Milewicz T, Gregoraszczuk EL, Augustowska K, Krzysiek J, Sztefko K, Rys J. Progesterone but not estradiol 17beta potentiates local GH secretions by hormone-dependent breast cancer explants. An in vitro study. Experimental Clinical Endocrinology and Diabetes 2005; 113: 127–132
  • Mogi C, Goda H, Mogi K, Takaki A, Yokoyama K, Tomida M, Inoue K. Multistep differentiation of GH-producing cells from their immature cells. Journal of Endocrinology 2005; 184: 41–50
  • Mohan PS, Jaya Rao KS. Plasma somatomedin activity in vitamin A deficient children. Clinica Chimica Acta 1979; 96: 241–246
  • Mohan R, Heyman RA. Orphan nuclear receptor modulators. Current Topics in Medicinal Chemistry 2003; 3: 1637–1647
  • Monteiro MG, Schuckit MA, Hauger R, Irwin M, Duthie LA. Growth hormone response to intravenous diazepam and placebo in 82 healthy men. Biological Psychiatry 1990; 27: 702–710
  • Moore RW, Parsons JA, Bookstaff RC, Peterson RE. Plasma concentrations of pituitary hormone in 2,3,7,8-tetrachlorodibenzo-p-dioxin treated male rats. Journal of Biochemical Toxicology 1989; 4: 165–172
  • Morales O, Faulds MH, Lindgren UJ, Haldosen LA. 1Alpha,25-dihydroxyvitamin D3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signalling via the Jaus kinase (JAK)/signal transducers and activators of transcription (STAT5) system in osteoblast cells. Journal of Biological Chemistry 2002; 277: 34879–34884
  • Morgan TM, Crawford L, Stoller A, Toth D, Yeo KT, Baron JA. Acute effects of nicotine on serum glucose insulin growth hormone and cortisol in healthy smokers. Metabolism 2004; 53: 578–582
  • Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD. Variation in plasma insulin-like growth factor-1 and insulin like growth factor binding protein-3: genetic factors. Cancer Epidemiology, Biomarkers and Prevention 2005a; 14: 1394–1401
  • Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors (United States). Cancer Causes and Control 2005b; 16: 917–927
  • Morita S, Matsuo K, Tsuruta M, Leng S, Yamashita S, Izumi M, Nagataki S. Stimulatory effect of retinoic acid on GH gene expression: the interaction of retinoic acid and tri-iodothyronine in rat pituitary cells. Journal of Endocrinology 1990; 125: 251–256
  • Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of TGF-beta signalling in regulation of cell growth and differentiation. Immunological Letters 2002; 82: 85–91
  • Mucci LA, Tamimi R, Lagiou P, Trichopoulou A, Benetou V, Spanos E, Trichopoulos D. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU International 2001; 87: 814–820
  • Muller AF, Van der Lely AJ. Pharmacological therapy for acromegaly: a critical review. Drugs 2004; 64: 1817–1838
  • Muller EE, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiological Reviews 1999; 79: 511–607
  • Murao K, Takahara J, Sato M, Tamaki M, Miimu M, Ishida T. Relationship between thyroid functions and urinary growth hormone secretion in patients with hyper- and hypothyroidism. Endocrine Journal 1994; 41: 517–522
  • Murray M, Butler AM, Fiala-Beer E, Su GM. Phospho-STAT5 accumulation in nuclear fractions from vitamin A-deficient rat liver. FEBS Letters 2005; 576: 3669–3673
  • Mutti A, Vescovi PP, Falzoi M, Arfini G, Valenti G, Franchini I. Neuroendocrine effects of styrene on occupationally exposed workers. Scandinavian Journal of Work Environment and Health 1984; 10: 225–228
  • Nagata C, Shimazu H, Takami R, Hayashi M, Takeda N, Yasuda K. Dietary soy and flats in relation to serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 levels in premenopausal Japanese women. Nutrition and Cancer 2003; 45: 185–189
  • Naidu KA, Karl RC, Naidu KA, Coppola D. Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor. Digestive Diseases and Science 2003; 48: 230–237
  • Naidu KA, Tang JL, Naidu KA, Prockop LD, Nicosia SV, Coppola D. Antiproliferative and apoptotic effect of ascorbyl stearate in human glioblastoma multiforme cells: modulation of inulin-like growth factor-1 receptor (IGF-1R) expression. Journal of Neuro-oncology 2001; 54: 15–22
  • Nakade O, Koyama H, Ariji H, Yajima A, Kaku T. Melatonin stimulates proliferation and type 1 collagen synthesis in human bone cells in vitro. Journal of Pineal Research 1999; 27: 106–110
  • Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochemical Pharmacology 2000; 59: 65–85
  • Netti C, Rapetti D, Sibilia V, Pagani F, Pecile A, Guidobono F. Endocrine effects of centrally injected nociceptin in the rat. Brain Research 2002; 938: 55–61
  • Nieves-Rivera F, Rgol AD, Veldhuis JD, Branscom DK, Martha PM, Jr, Clarke WL. Alterations in growth hormone secretion and clearance in adolescent boys with insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1993; 77: 638–643
  • Nilsson AB, Friberg P, Bonquist L, Lasaitiene D, Marcussen N, Chen Y. Growth hormone aggravates renal abnormalities induced by neonatal enalapril treatment. Journal of Paediatric Nephrology 2003; 18: 878–886
  • Nishikawa A, Mori Y, Lee IS, Tanaka T, Hirose M. Cigarette smoking, metabolic activation and carcinogenesis. Current Drug Metabolism 2004; 5: 363–373
  • Nogami H, Matsubara M, Harigaya T, Katayama M, Kawamura K. Retinoic acids and thyroid hormone act synergistically with dexamethasone to increase growth-hormone-releasing hormone receptor messenger ribonucleic acid expression. Endocrinology 2000; 141: 4396–4401
  • Nukaya M, Takahashi Y, Gonzalez F, Kamataki T. Aryl hydrocarbon receptor-mediated suppression of GH receptor and Janus kinase 2 expression in mice. FEBS Letters 2004; 558: 96–100
  • Nurenberger JI, Jr, Jimerseon DC, Simmons-Ailling S, Tamminga C, Nadi NS, Lawrence D, Sitaram N, Gillin JC, Gershon ES. Behavioural, physiological, and neuroendocrine responses to arecoline in normal twins and ‘well state’ bipolar patients. Psychiatry Research 1983; 9: 191–200
  • Obermayr RP, Mayerhofer L, Knechtelsdorfer M, Mersich N, Huber ER, Geyer G, Tragl KH. The age-related down regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease. Experimental Gerontology 2005; 40: 157–163
  • Ohlsson C, Lovstedt K, Holmes PV, Nilsson A, Carlsson L, Tornell J. Embryonic stem cells express growth hormone receptors: regulation by retinoic acid. Endocrinology 1993; 133: 2897–2903
  • Ohye H, Sato M, Matsubara S, Ohyama T, Murao K, Takahara J. Effects of immunosuppressant agents on growth hormone release and gene expression. Endocrine Journal 1998; 45(Suppl.)S93–96
  • Oliveira MR, Ohnuma L, Bendit I, Dorlhiac-Lacer P, Giannella-Neto D. Interferon-alpha therapy increases type 1 insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukaemia. Leukaemia Research 2001; 25: 711–717
  • Orio F, Jr, Palomba S, Colao A, Tenuta M, Dentico C, Petretta M, Lombardi G, Nappi C, Orio F. Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women. Hormone Research 2001; 55: 131–136
  • Osafo J, Wei Y, Kenth G, Goodyer CG. Growth hormone during development. Reviews in Endocrine and Metabolic Disorders 2005; 6: 175–182
  • Pagliacci MC, Smacchia M, Migliorati G, Grignani F, Riccardi C, Nicoletti I. Growth-inhibitory effects of the natural phyto-estrogen genistein in MCF-7 human breast cancer cells. European Journal of Cancer 1994; 30A: 1675–1682
  • Palka J, Bird TA, Oyamada I, Peterkofsky B. Similar hormonal changes in sera from scorbutic and fasted (vitamin C-supplemented) guinea pigs, including decreased IGF-1 and appearance of an IGF-1 reversible mitogenic inhibitor. Growth Factors 1989; 1: 147–156
  • Pandini G, Mineo R, Frasca F, Roberts CT, Jr, Marcelli M, Vigneri R, Belifore A. Androgens up-regulate the insulin-like growth factor-1 receptor in prostate cancer cells. Cancer Research 2005; 65: 1849–1857
  • Park JH, Hahn EJ, Kong JH, Cho HJ, Yoon CS, Cheong SW, Oh GS, Youn HJ. TCDD-induced apoptosis in EL-4 cells deficient of the aryl hydrocarbon receptor and down-regulation of IGFBP-6 prevented the apoptotic cell death. Toxicological Letters 2003; 145: 55–68
  • Park S, Waxman DJ. Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3β. Journal of Biological Chemistry 2001; 276: 43031–43039
  • Pawlikowski M, Kolomecka M, Wojtczak A, Karasek M. Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulphate, and somatomedin C in elderly women. Neuro Endocrinology Letters 2002; 23(Suppl. 1)17–19
  • Pell JM, Salih DAM, Cobb LJ, Tripathi G, Drozd A. The role of insulin-like growth factor binding proteins in development. Reviews in Endocrine and Metabolic Disorders 2005; 6: 189–198
  • Peterkofsky B, Gosiewska A, Kipp DE, Shah V, Wilson S. Circulating insulin-like growth factor binding proteins (IGFBPs) 1 and 2 induced in vitamin C-deficient or fasted guinea pigs inhibit IGF-1 action in cultured cells. Growth Factors 1994; 10: 229–241
  • Petit A, Bleicher C, Lussier BT. Intracellular calcium stores are involved in growth hormone-releasing hormone signal transduction in rat somatotropes. Canadian Journal of Physiology and Pharmacology 1999; 77: 520–528
  • Philip JG, John CD, Cover PO, Morris JF, Christian HC, Flower RJ, Buckingham JC. Opposing influences of glucocorticoids and interleukin-1beta on the secretion of growth hormone and ACTH in the rat in vivo: role of hypothalamic annexin 1. British Journal of Pharmacology 2001; 134: 887–895
  • Pinessi I, Rainero I, Valfre W, Lo Giudice R, Ferrero M, Rivoiro C, Arvat E, Gianotti L, Del P, Limone P. Abnormal 5-HT1D receptor function in cluster headache: a neuroendocrine study with sumitriptan. Cephalalgia 2003; 23: 354–360
  • Pitchot W, Wauthy J, Legros JJ, Ansseau M. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study. European Journal of Neuropsychopharmacology 2004; 14: 151–155
  • Pittoni G, Gallioi G, Zanello M, Gianotti L, Boghen MF, Colombo S, Broglio F, Santoro C, Davia G, Papini MG, Destefanis S, Minuto F, Miola C, Ghigo E. Activity of GH/IGF-1 axis in trauma and septic patients during artificial nutrition: different behaviour patterns? Journal of Endocrinological Investigation 2002; 25: 214–223
  • Plant N. Interaction networks: coordinating responses to xenobiotic exposure. Toxicology 2004; 202: 21–32
  • Poeggeler B. Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy. Endocrine 2005; 27: 201–212
  • Pontiroli AE, Viberti G, Vicari A, Pozza G. Effect of the antihistaminic agents meclastine and dexchlorpheniramine on the response of human growth hormone to arginine infusion and insulin hypoglycaemia. Journal of Clinical Endocrinology and Metabolism 1976; 43: 582–586
  • Porter RJ, Galalgher P, Watson S, Lunn BS, Young AH. The effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers. Pschychopharmacology 2002; 163: 68–75
  • Porter WP, Green SM, Debbink NL, Carlson I. Groundwater pesticides: interactive effects of low concentrations of carbamates aldicarb and methomyl and the triazine methribuzin on thyroxine and somatotrophin levels in white rats. Journal of Toxicology and Environmental Health 1993; 40: 15–34
  • Pouwels MJ, Jacobs JR, Span PN, Lutterman JA, Smts P, Tack CJ. Short-term glucosamine infusion does not affect insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2001; 86: 2099–2103
  • Poykko SM, Ukkola O, Kauma H, Kellokoski E, Horkko S, Kesaniemi YA. The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes. Diabetologica 2005; 48: 309–316
  • Pringle PJ, Geary MP, Rodeck CH, Kingdom JC, Kayamba-Kay's S, Hindmarsh PC. The influence of cigarette smoking on antenatal growth, birth size, and the insulin-like growth factor axis. Journal of Clinical Endocrinology and Metabolism 2005; 90: 2556–2562
  • Probst-Hensch NM, Wang H, Goh VHH, Seow A, Lee HP, Yu MC. Determinants of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiology, Biomarkers and Prevention 2003; 12: 739–746
  • Qin LQ, Xu JY, Wang PY, Ganmaa D, Li J, Wang J, Kaneko T, Hoshi K, Shirai T, Sato A. Low-fat milk promotes the development of 7,12-dimethylbenz(A)anthracene (DMBA)-induced mammary tumors in rats. International Journal of Cancer 2004; 110: 491–496
  • Raifen R, Altman Y, Zadik Z. Vitamin A levels and growth hormone axis. Hormone Research 1996; 46: 279–281
  • Rajah R, Nunn SE, Herrick DJ, Grunstein MM, Cohen P. Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscles cells. American Journal of Physiology 1996; 271: L1014–L
  • Randi AS, Cocca C, Carbone V, Nunez M, Croci M, Gutierrez A, Bergoc R, De Pisarev DL. Hexachlorobenzene is a tumor co-carcinogen and induces alterations in insulin-growth factors signalling pathway in the rat mammary gland. Toxicological Sciences 2005; 89: 83–92
  • Ranke MB. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance. Trends in Endocrinology and Metabolism 2005; 16: 190–197
  • Rao RK, Philipps AF, Williams CS, McCracken DM, Koldovsky O. Luminal stability of insulin-like growth factors 1 and 2 in developing rat gastrointestinal tract. Journal of Pediatric Gastroenterology and Nutrition 1998; 26: 179–185
  • Rasmussen BB, Brix TH, Kyvik KO, Brosen K. The interindividual differences in the 3-demethylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 2002; 12: 473–478
  • Ren MQ, Kuhn G, Wegner J, Nurnberg G, Checn J, Ender K. Feeding daidzein to late pregnant sows influences the estrogen receptor beta and type 1 insulin-like growth factor receptor mRNA expression in newborn piglets. Journal of Endocrinology 2001; 170: 129–135
  • Renehan AG, Atkin WS, O’Dwyer ST, Shalet SM. The effect of cigarette smoking use and cessation on serum insulin-like growth factors. British Journal of Cancer 2004; 91: 1525–1531
  • Ribeiro MF, Garcia-Segura LM. Dehydroepiandrosterone regulates insulin-like growth factor-1 in rat hypothalamus. Endocrine 2002; 17: 129–134
  • Ricchi P, Pignata S, Di Popolo A, Memoli A, Apicella A, Zarrilli R, Acquaviva AM. Effect of asprin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells. International Journal of Cancer 1997; 73: 880–884
  • Rickard SE, Yuan YV, Thompson LU. Plasma insulin-like growth factor 1 levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside. Cancer Letters 2000; 161: 47–55
  • Riley LG, Fox BK, Kaiya H, Hirano T, Grau EG. Long-term treatment of ghrelin stimulates feeding, fat deposition, and alters the GH/IGF-1 axis in the tilapia Oreochromis mossambicus. General and Comparative Endocrinology 2005; 142: 234–240
  • Robson H, Siebler T, Shalet SM, Williams GR. Interactions between GH, IGF-1, glucocorticoids and thyroid hormones during skeletal growth. Paediatric Research 2002; 52: 137–147
  • Rochira V, Balestrieri A, Faustini-Fustini M, Borgato S, Beck-Pecoz P, Carani C. Pituitary function in a man with congenital aromatase deficiency: effect of different doses of transdermal E2 on basal and stimulated pituitary hormones. Journal of Clinical Endocrinology and Metabolism 2002; 87: 2857–2862
  • Rogers IS, Gunnell D, Emmett PM, Glynn LR, Dunger DB, Holly JM. Cross-sectional associations of diet and insulin-like growth factor levels in 7- to 8-year-old children. Cancer Epidemiology, Biomarkers and Prevention 2005; 14: 204–212
  • Rojdmark S, Calissendorff J, Danielsson O, Brismar K. Hunger-satiety signals in patients with Graves’ thyrotoxicosis before, during, and after long-term pharmacological treatment. Endocrine 2005; 27: 55–61
  • Rojdmark S, Rydvald Y, Aquilonius A, Brismar K. Insulin-like growth factor (IGF-1)-1 and IGF-binding protein-1 concentrations in serum of normal subjects after alcohol ingestion: evidence for decreased IGF-1 bioavailability. Clinical Endocrinology 2000; 52: 313–318
  • Roman J, Villaizan CJ, Garcia-Foncillas J, Salvador J, Sierraseumaga L. Growth and growth hormone secretion in children with cancer treated with chemotherapy. Journal of Pediatrics 1997; 131: 105–112
  • Rooman RP, De Beeck LO, Martin M, Van Doorn J, Mohan S, Du Caju MV. Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature. European Journal of Endocrinology 2005; 152: 597–604
  • Rose SR, Schriber RE, Kearney NS, Lustig RH, Danish RK, Burghen GA, Hudson MM. Hypothalamic dysfunction after chemotherapy. Journal of Pediatric Endocrinology and Metabolism 2004; 17: 55–66
  • Rosen CJ, Bilezikian JP. Critical Review 123: Anabolic therapy for osteoporosis. The Journal of Clinical Endocrinology and Metabolism 2001; 86: 957–964
  • Rosenfeld RG. The molecular basis of idiopathic short stature. Growth Hormone and IGF Research 2005; 15(Suppl. A)S3–S5
  • Ross RJM. GH, IGF-1 and binding proteins in altered nutritional states. International Journal of Obesity 2000; 24(Suppl. 2)S92–S95
  • Roy-Byrne PP, Cowley DS, Hommer D, Ritchie J, Greenblatt D, Nemeroff C. Neuroendocrine effects of diazepam in panic and generalized anxiety disorders. Biological Psychiatry 1991; 30: 73–80
  • Ruiz A, Tebar M, Perez-Romero A, Rol De Lama MA, Sanchez-Criado JE. Serum levels of GH, IGF-, LH and ovarian steroids in cyclic and RU-486-treated rats. Journal of Endocrinological Investigation 1997; 20: 611–615
  • Russell-Jones DL, Umpleby AM, Shojaee-Moradie F, Boroujerdi MA, Jones RH, Baxter RC, Sonksen PH. The effect of an intravenous infusion of IGF-1 and insulin on IGFBP-1, IGFBP-3, acid labile subunit, free and bound IGF-1, catecholamines and potassium in normal volunteers during an amino acid and glucose clamp. Clinical Endocrinology 1997; 47: 685–691
  • Sakai K, Clemmons DR. Glucosamine induces resistance to insulin-like growth factor 1 (IGF-1) and insulin in Hep G2 cell cultures: biological significance of IGF-1/insulin hybrid receptors. Endocrinology 2003; 144: 2388–2395
  • Sallee FR, Sethuraman G, Sine L, Liu H. Yohimbine challenge in children with anxiety disorders. American Journal of Psychiatry 2000; 157: 1236–1242
  • Santolaria F, Gonzalez-Gonzalez G, Gonzalez-Reimers E, Martinez-Tiera A, Milena A, Rodriguez-Moreno F, Gonzalez-Garcia C. Effects of alcohol and liver cirrhosis on the GH–IGF-1 axis. Alcohol and Alcoholism 1995; 30: 703–708
  • Satoh K, Sakamoto Y, Ogata A, Nagia F, Mikuriya H, Numazawa M, Yamada K, Aoki N. Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats. Food and Chemical Toxicology 2002; 40: 925–933
  • Scarlett JA, Zeidler A, Rochman H, Rubenstein A. Acute effects of ascorbic acid infusion on carbohydrate tolerance. American Journal of Clinical Nutrition 1976; 29: 1339–1342
  • Schaeffer HJ, Sirotkin AV. Melatonin and serotonin regulate the release of insulin-like growth factor-1, oxytocin and progesterone by cultured human granulosa cells. Experimental and Clinical Endocrinology and Diabetes 1997; 105: 109–112
  • Schedlich LJ, O’Han MK, Leong GM, Baxter RC. Insulin-like growth factor binding-protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells. Biochemical and Biophysical Research Communications 2004; 314: 83–88
  • Schernhammer ES, Hankinson SE, Hunter DJ, Blouin MJ, Pollak MN. Polymorphic variation at the -202 locus in IGFBP3: influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. International Journal of Cancer 2003; 701: 60–64
  • Schmid C, Ghirlanda-Keller C, Gosteli-Peter M. Ascorbic acid decreases neutral endopeptidase activity in cultured osteoblastic cells. Regulatory Peptides 2005; 130: 57–66
  • Schmitt JK. Indomethacin increases plasma growth hormone levels in man. American Journal of Medical Science 1990; 300: 144–147
  • Schmitt JK. Ibuprofen fails to increase plasma growth hormone levels in humans. American Journal of Medical Science 1993; 305: 289–291
  • Schule C, Baghai T, Sauer N, Laakman G. Endocrinological effects of high-dose Hypericum perforatum extracts WS 5570 in healthy subjects. Neuropsychobiology 2004; 49: 58–63
  • Schultze-Mosagau A, Griesinger G, Altgassen C, Von S, Hornung D, Diedrich K. New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists. Expert Opinion on Investigational Drugs 2005; 14: 1085–1097
  • Seoane S, Alonso M, Segura C, Perez-Fernandez R. Localization of a negative vitamin D response sequence in the human growth hormone gene. Biochemical and Biophysical Research Communications 2002; 292: 250–255
  • Seto D, Zheng WH, McNicoll A, Collier B, Quirion R, Kar S. Insulin-like growth factor-1 inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects. Neuroscience 2002; 115: 603–612
  • Shang Y, Baumrucker CR, Green MH. Signal relay by retinoic acid receptors alpha and beta in the retinoic acid-induced expression of insulin-like growth factor-binding protein-3 in breast cancer. Journal of Biological Chemistry 1999; 274: 18005–18010
  • Shen WH, Xu RJ. Stability of insulin-like growth factor 1 in the gastrointestinal lumen of neonatal pigs. Journal of Pediatric Gastroenterology and Nutrition 2000; 30: 299–304
  • Shimizu M, Deguchi A, Hara Y, Mariwaki H, Weinstein AB. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochemical and Biophysical Research Communications 2005; 334: 947–953
  • Shipley JM, Waxman DJ. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b. Toxicology and Applied Pharmacology 2004; 199: 275–284
  • Shorrab AA, Atallah MM. Total intravenous anaesthesia with ketamine-midazolam versus halothane-nitrous oxide-oxygen anaesthesia for prolonged abdominal surgery. European Journal of Anaesthesiology 2003; 20: 925–931
  • Shukla S, Mishra A, Fu P, Maclennan GT, Resnick MI, Gupta S. Up-regulation of insulin-like growth factor binding-protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic mice. FASEB Journal 2005; 19: 2042–2044
  • Shumate ML, Yumet G, Ahmed TA, Cooney RN. Interleukin-1 inhibits the induction of insulin-like growth factor-1 by growth hormone in CWSV-1 hepatocytes. American Journal of Physiology. Gastrointestinal and Liver Physiology 2005; 289: G227–G239
  • Signorello LB, Kuer H, Lagiou P, Wuu J, Mucci LA, Trichopoulos D, Adami HO. Lifestyle factors and insulin-like growth factor 1 levels among elderly men. European Journal of Cancer Prevention 2000; 9: 173–178
  • Siler U, Barella L, Spitzer V, Schnorr J, Lein M, Goraleczyk R, Wertz K. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB Journal 2004; 18: 1019–1021
  • Singh A, Papanicolaou DA, Lawrence LL, Howell EA, Chrousos GP, Deuster PA. Neuroendocrine responses to running in women after zinc and vitamin E supplementation. Medicine and Science in Sports and Exercise 1999; 31: 536–542
  • Singh YN. Potential for interaction of kava and St. John's Wort with drugs. Journal of Ethnopharmacology 2005; 100: 108–113
  • Sirtori CR, Arnoldi A, Johnson SK. Phytoestogens: end of a tale? Annals of Medicine 2005; 37: 423–438
  • Sitruk-Ware R. Pharmacological profile of progestins. Maturitas 2004; 47: 277–283
  • Skrumsager BK, Christensen JV, Snel S, Seiberling M. Tolerability, safety and pharmacokinetics of single dose and multiple dosing of the selective D1 antagonist NNC 01-0687 in healthy subjects. Psychopharmacology 1995; 121: 294–299
  • Slattery ML, Baumgartner KB, Byers T, Guiliano A, Sweeney C, Herrick J, Curtin K, Murtaugh M, Wolff R. Genetic, anthropometric, and life-style factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women. Cancer Causes and Control 2005; 16: 1147–1157
  • Slootweg MC, Salles JP, Ohlsson C, De Vries CP, Engelbregt MJ, Netelenbos JC. Growth hormone binds to a single high affinity receptor site on mouse osteoblasts: modulation by retinoic acid and cell differentiation. Journal of Endocrinology 1996; 150: 465–472
  • Smallridge RC, Carr FE, Fein HG. Diisopropylfluorophosphate (DFP) reduces serum prolactin, thyrotropin, luteinising hormone, and growth hormone and increases adrenocorticotropin and corticosterone in rats: involvement of dopaminergic and somatostatinergic as well as cholinergic pathways. Toxicology and Applied Pharmacology 1991; 108: 284–295
  • Smith AG, Davies R, Dalton TP, Miller ML, Judah D, Riley J, Gant T, Nebert DW. Intrinsic hepatic phenotype associated with the CYP1a2 gene as shown by cDNA expression microarray analysis of the knock-out mouse. Toxicogenomics 2003; 111: 855–861
  • Smith RG. Development of growth hormone secretagogues. Endocrine Reviews 2005; 26: 346–360
  • Smolka MN, Budde H, Karow AC, Schmidt LG. Neuroendocrinological and neuropshychological correlates of dopaminergic function in nicotine dependence. Psychopharmacology 2004; 175: 374–381
  • Sneddon AA, Delday MI, Steven J, Maltin CA. Elevated IGF-2 mRNA and phosphorylation of 4E-BP1 and p70(S6k) in muscle showing clenbuterol-induced anabolism. American Journal of Physiology, Endocrinology and Metabolism 2001; 281: E676–E682
  • Soares-Welch C, Mielke KL, Bowers CY, Veldhuis JD. Short-term testosterone supplementation does not activate GH and IGF-1 production in postmenopausal women. Clinical Endocrinology 2005; 63: 32–38
  • Solerte SB, Gornati R, Cravello L, Albertelli N, Oberti S, Perotta D, Rossi G, Cuzzoni G, Ferrari E, Fioravanti M. Dehydroeipandrosterone-sulfate (DHEA-S) restores the release of IGF-1 from natural killer (NK) immune in old patients with dementia of Alheimer's type (DAT). Journal of Endocrinological Investigation 1999; 22(10 Suppl.)32–34
  • Soliman AT, Aref MK, Rogol AD. Arginine-induced insulin and growth hormone secretion in children with nutritional rickets. Journal of Pediatric Gastroenterology and Nutrition 1987; 6: 589–592
  • Soto L, Martin AI, Vara E, Lopez-Calderon A. Cyclosporin A treatment is able to revert the secrease in circulating GH and IGF-1 and the increase in IGFBPs induced by adjuvant arthritis. Hormone and Metabolic Research 2001; 33: 590–595
  • Spindel E. Action of the methylxanthines on the pituitary and pituitary-dependent hormones. Progress in Clinical and Biological Research 1984a; 158: 355–363
  • Spindel E. Neuroendocrine effects of caffeine in normal subjects. Clinical Pharmacology and Therapeutics 1984b; 36: 402–407
  • Srivastava VK, Dearth RK, Hiney JK, Chandrashekar V, Mattison JA, Bartke A, Dess WL. Alcohol suppresses insulin-like growth factor-1 gene expression in pubertal transgenic female mice overexpressing the bovine growth hormone gene. Alcoholism, Clinical and Experimental Research 2002; 26: 1697–1702
  • Stopper H, Schmitt E, Kobras K. Genotoxicity of phytoestrogens. Mutation Research 2005; 574: 139–155
  • Stulnig TM, Steffensen KR, Gao H, Reimers M, Dahlman-Wright K, Schuster GU, Gustafsson J. Novel roles of liver X receptor exposed by gene expression profiling in liver and adipose tissue. Molecular Pharmacology 2002; 62: 1299–1305
  • Suarez C, Vela J, Garcia-Tornadu I, Becu-Villalobos D. Dehydroepiandrosterone (DHEA) modulates GHRH, somatostatin and angiotensin 2 action at the pituitary level. Journal of Endocrinology 2005; 185: 165–172
  • Sueoka N, Lee HY, Walsh GL, Fang B, Ji L, Roth JA, LaPushin R, Hong WK, Cohen P, Kurie JM. Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abundance with all-trans-retioic acid treatment. American Journal of Respiratory Cell and Molecular Biology 2000; 23: 297–303
  • Szostak-Wegierek D, Bjorntorp P, Marin P, Lindstedt G, Andersson B. Influence of smoking on hormone secretion in obese and lean female smokers. Obesity Research 1996; 4: 321–328
  • Tang L, Bernardo O, Bolduc C, Lui H, Madani S, Shapiro J. The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia. Journal of the American Academy of Dermatology 2003; 49: 229–233
  • Tannheimer SL, Ethier SP, Caldwell KK, Burchiel SW. Benzo[a]pyrene and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signalling pathways in the MCF-10A human mammary epithelial cell line. Carcinogenesis 1998; 19: 1291–1297
  • Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocrine Reviews 1994; 15: 80–101
  • Timsit YE, Riddick DS. Stimulation of hepatic signal transducer and activator of transcription 5b by GH is not altered by 3-methylcholanthrene. Endocrinology 2002; 143: 3284–3294
  • Tokar EJ, Webber MM. Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells. Clinical and Experimental Metastasis 2005; 22: 265–273
  • Tomei F, Ciarrocca M, Rosati MV, Baccolo TP, Fiore P, Perrone P, Tomao E. Occupational exposure to urban pollutants and plasma insulin-like growth factor-1 (IGF-1). International Journal of Environmental Health Research 2004; 14: 135–142
  • Tomei F, Rosati MV, Baccolo TP, Morelli A, Anzelmo V, Ciarrocca M, Tomao E. Occupational exposure to urban pollutants and plasma growth hormone (GH). Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances and Environmental Engineering 2003; 38: 1017–1024
  • Toogood AA. The somatopause: an indication for growth hormone therapy? Treatments in Endocrinology 2004; 3: 201–209
  • Torrado J, Carracosa C. Pharmacological characteristics of parental IGF-1 administration. Current Pharmaceutical Biotechnology 2003; 4: 123–140
  • Tronche F, Opherk C, Moriggi R, Kellendonk C, Reimann A, Schwake L, Reichardt HM, Stagl K, Gau D, Hoeflich A, Beug H, Schmid W, Schultz G. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes and Development 2004; 18: 492–497
  • Tseng M, Breslow RA, Graubard BI, Ziegler RG. Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. American Journal of Clinical Nutrition 2005; 81: 1147–1154
  • Tulipano G, Rossi E, Culler MD, Taylor JE, Bonadonna S, Locatelli V, Cocchi D, Giustina A. The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. Regulatory Peptides 2005; 125: 85–92
  • Turner BC, Jenkins E, Kerr D, Sherwin RS, Cavan DA. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care 2001; 24: 1888–1893
  • Turner CH, Garetto LP, Dunipace AJ, Zhang W, Wilson ME, Grynpas MD, Chachra D, McClintok R, Peacock M, Stookey GK. Fluoride treatment increased serum IGF-1, bone turnover, and bone mass, but not bone strength in rabbits. Calcified Tissue International 1997; 61: 77–83
  • Turner EH, Loftis JM, Blackwell AD. Serotinin a la carte: supplementation with the serotonin precursor 5-hydrocytryptophan. Pharmacological Therapeutics 2005; 109: 325–338
  • Turner KJ, McIntye BS, Phillips SL, Barlow NJ, Bowman CJ, Foster PMD. Altered gene expression during rat wolffian duct development in response to in utero exposure to the antiandrogen liuron. Toxicological Sciences 2003; 74: 114–128
  • Uhde TW, Tancer ME, Rubinow DR, Roscow DB, Boulenger JP, Vittone B, Gurguis G, Geraci M, Black B, Post RM. Evidence for hypothalmo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy controls. Neuropsychopharmacology 1992; 6: 101–118
  • Upadhyaya HP, Brady KT, Liao J, Sethuraman G, Middaugh L, Wharton M, Sallee FR. Neuroendocrine and behavioural responses to dopaminergic agonists in adolescents with alcohol abuse. Psychopharmacology 2003; 166: 95–101
  • Ur E, Wright DM, Bouloux PM, Grossman A. The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man. British Journal of Pharmacology 1997; 120: 781–784
  • Valcavi R, Dieguez C, Zini M, Murais C, Casanueva F, Portioli I. Influence of hyperthyroidism on growth hormone secretion. Clinical Endocrinology 1993; 38: 515–522
  • Van Cauter E, Latta E, Nedeltcheva A, Spiegel K, Leproult R, Vandenbril C, Weiss R, Mockel J, Legros JJ, Copinschi G. Reciprocal interaction between GH axis and sleep. Growth Hormone and IGF Research 2004; 14(Suppl. A)S10–S17
  • Van Cauter E, Plat L, Scharf MB, Leproult R, Cespedes S, L’Hermite-Baleriaux M, Copinschi G. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydrobutyrate in normal young men. Journal of Clinical Investigation 1997; 100: 745–753
  • Van der Ven LT, Van Buul-Offers SC, Gloudemans T, Roholl PJ, Sussenbach JS, Den Otter W. Histamine-stimulated expression of insulin-like growth factors in human glioma cells. British Journal of Cancer 1997; 75: 1091–1097
  • Van Eickels M, Vetter H, Grohe C. Angiotensin-converting enzyme (ACE) inhibition attenuates insulin-like growth factor-1 (IGF-1) induced cardiac fibroblast proliferation. British Journal of Pharmacology 2000; 131: 1592–1596
  • Van D, Beekman M, Mooijaart SP, Hijmans BT, Brandt BW, Zwann BJ, Slagboom PE, Westendorp RG. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 2005; 4: 79–85
  • Van Neck JW, Cingel V, Van Vilet AK, Drop SL, Flyvbjerg A. High-protein induced renal enlargement is growth hormone independent. Kidney International 2002; 62: 1187–1195
  • Van Santen HM, Thonissen NM, De Kraker J, Vulsma T. Changes in thyroid hormone state in children receiving chemotherapy. Clinical Endocrinology 2005; 62: 250–257
  • Veldhuis JD. Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender. Growth Hormone and IGF Research 1998, Suppl.: 49–59
  • Veldhuis JD, Keenan DM, Mielke K, Miles JM, Bowers CY. Testosterone supplementation in healthy older men drives GH and IGF-1 secretion without potentiating peptidyl secretagogue efficacy. European Journal of Endocrinology 2005; 153: 577–586
  • Vescovi PP, Coiro V. Different control of GH secretion by gamma-amino- and gamma-hydroxy-butyric acid in 4-year abstinent alcoholics. Drug and Alcohol Dependence 2001; 61: 217–221
  • Villa P, Valle D, De Marinis L, Mancini A, Bianchi A, Fulghesu AM, Caruso A, Mancuso S, Lanzone A. Influence of chronic naltrexone treatment on growth hormone secretion in normal subjects. European Journal of Endocrinology 1997; 137: 631–634
  • Villareal DT, Holloszy JO, Kohrt WM. Effects of DHEA replacement on bone mineral density in elderly men and women. Clinical Endocrinology 2000; 53: 561–568
  • Vinggaard AM, Jacobsen H, Metzdorff SB, Andersen HR, Nellmann C. Antiandrogenic effects in short-term in vivo studies of the fungicide fenarimol. Toxicology 2005; 207: 21–34
  • Volek JS, Ratamess NA, Rubin MR, Gomez AL, French DN, McGuigan MM, Schett TP, Darman MJ, Hakkinen K, Kraemer WJ. The effects of creatine supplementation on muscular performance and body composition responses to short-term resistance training overreaching. European Journal of Applied Physiology 2004; 91: 628–637
  • Volpi R, Chiodera P, Caffarra P, Scaglioni A, Malvezzi L, Saginario A, Coiro V. Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects. Psychoneuroendocrinology 2000; 25: 179–185
  • Voskuil DW, Vrieling A, Van't Veer LJ, Kampman E, Rookus MA. The insulin-like growth factor system in cancer prevention: potential of dietary intervention strategies. Cancer Epidemiology, Biomarkers and Prevention 2005; 14: 195–203
  • Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, Van Noord PA, Keinan-Boker L, Van Gils CH, Peeters PH. Dietary determinants of circulating insulin-like growth factor (IGF-1)-1 and IGF binding proteins 1, -2 and -3 in women in the Netherlands. Cancer Causes and Control 2004; 15: 787–796
  • Vyas S, Asmerom Y, De Leon DD. Resveratrol regulates insulin-like growth factor-2 in breast cancer cells. Endocrinology 2005; 146: 4224–4233
  • Wang S, DeGroff VL, Clinton SK. Tomato and soy polyphenols reduce insulin-like growth factor-1-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signalling pathways involving tyrosine kinase. Journal of Nutrition 2003; 133: 2367–2376
  • Wang X. Can smoke exposed ferrets be utilized to unravel the mechanisms of action of lycopene? American Society for Nutritional Sciences Journal of Nutrition 2005; 135: 2053S–2056S
  • Watanabe CM, Wolffram S, Ader P, Rimbach G, Packer L, Maguire JJ, Schultz PG, Gohil K. The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proceedings of the National Academy of Sciences, USA 2001; 98: 6577–6580
  • Weintrob N, Cohen D, Klipper-Aurbach Y, Zadi Z, Dickerman Z. Decreased growth during therapy with the selective serotonin re-uptake inhibitors. Archives of Paediatric and Adolescent Medicine 2002; 156: 696–701
  • Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, Karalis A, Mantzoros CS. Recombinant human leptin in women with hypothalamic amenorrhea. New England Journal of Medicine 2004; 351: 987–997
  • Westwood M, Gibson JM, Pennells LA, White A. Modification of plasma insulin-like growth factors and binding proteins during oral contraceptive use and the normal menstrual cycle. American Journal of Obstetrics and Gynaecology 1999; 180: 530–536
  • Wetzel H, Wiesner J, Hiemke C, Benkert O. Acute antagonism of dopamine D2-receptors by amisulpride: effects on hormone secretion in healthy volunteers. Journal of Psychiatric Research 1994; 28: 461–473
  • Wiedemann K, Lauer C, Pollmacher T, Holsboer F. Sleep endocrine effects of antigluco- and antimineralocorticoids in healthy males. American Journal of Physiology 1994; 267: E109–E114
  • Wietrzyk J, Grynkiewicz G, Polski A. Phytoestrogens in cancer prevention and therapy — mechanisms of their biological activity. Anticancer Research 2005; 25: 2357–2366
  • Wilkins JN, Carlson HE, Van Vunakis H, Hill MA, Gritz E, Jarvik ME. Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology 1982; 78: 305–308
  • Williams CL, Lennon VA. Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma. Cell Regulation 1991; 2: 373–381
  • Wilson ME, Fisher J, Chikazawa K, Yoda R, Legendre A, Mook D, Gould KG. Leptin administration increases nocturnal concentrations of luteinizing hormone and growth hormone in juvenile female rhesus monkeys. Journal of Clinical Endocrinology and Metabolism 2003; 88: 4874–4883
  • Wilson VS, Lambright C, Furr J, Ostby J, Wood C, Held G, Gray LE, Jr. Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicology Letters 2004; 146: 207–215
  • Woelfe J, Chia J, Massart-Schlesinger MB, Moyano P, Rotwein P. Molecular physiology, pathology and regulation of the growth hormone–insulin-like growth factor-1 system. Pediatric Nephrology 2005; 21: 295–302
  • Woodside JV, Campbell MJ, Danholm EE, Newton L, Honour JW, Morton MS, Young IS, Leathem AJ. Short-term phytoestrogen supplementation alters insulin-like growth factor profile but not lipid or antioxidant status. Journal of Nutritional Biochemistry 2005; 17: 211–215
  • Wu Q, Ohsako S, Ishimura R, Suzuki JS, Tohyama C. Exposure of mouse preimplantation embryos to 2,3,7,8-tetrachlordibenzo-p-dioxin (TCDD) alters the methylation status of imprinted genes H19 and Igf2. Biology of Reproduction 2004; 70: 1790–1797
  • Xie SP, Pirianov G, Colston KW. Vitamin D analogues suppress IGF-1 signalling and promote apoptosis in breast cancer cells. European Journal of Cancer 1999; 35: 1717–1723
  • Yang YW, Pioli P, Fiorelli G, Brandi ML, Rechler MM. Cyclic adenosine monophosphate stimulates insulin-like growth factor binding protein-4 and its messenger ribonucleic acid in a clonal endothelial cell line. Endocrinology 1993; 133: 343–351
  • Yang Y, Wang W, Su Y. Retinoic acid regulates insulin-like growth factor gene expression in cord lymphosytes. Chinese Medical Journal 2001; 114: 170–172
  • Yasumaru M, Tsuji S, Tsuji M, Irie T, Komuri M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Hayashi N, Kawano S, Hori M. Inhibition of angiotensin 2 activity enhanced the antitumour effect of cyclooxygenase-2 inhibitors via insulin-like growth factor 1 receptor pathway. Cancer Research 2003; 63: 6726–6734
  • Yimlamai T, Dodd SL, Borst SE, Park S. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. Journal of Applied Physiology 2005; 99: 71–80
  • Yoo A, Tanimoto H, Akesson K, Baylink DJ, Lau KH. Effects of calcium depletion and repletion on serum insulin-like growth factor 1 and binding protein levels in weanling rats. Bone 1998; 22: 225–232
  • Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. Plasma levels of insulin-like growth factor-1 and lung cancer risk: a case-control analysis. Journal of the National Cancer Institute 1999; 91: 151–156
  • Yu ZP, Le GW, Shi YH. Effect of zinc sulphate and zinc methionine on growth, plasma growth hormone concentration, growth hormone receptor and insulin-like growth factor-1 gene expression in mice. Clinical and Experimental Pharmacology and Physiology 2005; 32: 273–278
  • Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK. Soybean phytocehmicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. Journal of Nutrition 1999; 129: 1628–1635
  • Zimmermann-Belsing T, Juul A, Juul Holst J, Feldt-Rasmusen U. The insulin-like growth factor axis in patients with auto-immune thyrotoxicosis: effect of anti-thyroid drug treatment. Growth Hormone and IGF Research 2004; 14: 235–244
  • Zofkova I, Kancheva RL, Bendlova B. Effect of 1,25(OH)2-vitamin D3 on circulating insulin-like growth factor-1 and beta 2 microglobulin in patients with osteoporosis. Calcified Tissue International 1997; 60: 236–239

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.